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Cardiac ventricular arrhythmia is still the most common cause of sudden 
cardiac death occurring in about 1:1000 inhabitants per year (1). In individuals 
below 40 years of age, inherited cardiac disease is the most frequent cause of 
ventricular arrhythmias, while coronary artery disease is most common in 
individuals above 40 years of age. In this thesis, patients with increased risk of 
ventricular arrhythmias and sudden cardiac death from both categories were 
included with the overall aim to evaluate the role of novel echocardiographic 
techniques in risk stratification of ventricular arrhythmias. 
The long QT syndrome 
The long QT syndrome (LQTS) is an inherited cardiac arrhythmic disease 
predisposing to life threatening ventricular arrhythmias and sudden cardiac death. 
Mutations in genes encoding for cardiac ion channels are leading to prolonged 
action potential duration and dispersion of action potential repolarization which 
are considered to be important mechanisms behind the arrhythmias in these 
patients (Figure 1). Risk stratification for ventricular arrhythmias in LQTS patients 
is currently based on history of syncope, genotype, gender and heart rate corrected 
QT interval (QTc) on ECG (2). Prolonged QTc reflects prolonged myocardial 
action potential duration (APD). Earlier invasive studies have indicated that APD 
is not homogeneously distributed throughout the myocardium neither in healthy 
humans nor in genetically altered myocardium (3-6). Inhomogeneous end of APD 
has been reported as dispersion of electrical repolarization (7). In LQTS patients, 
this dispersion of APD leads to a marked electrical dispersion of repolarization 
which is important in arrhythmogenesis and the development of Torsade de 
pointes ventricular arrhythmia (Figure 1) 
Figure 1. Mechanisms of arrhythmias in LQTS. Potassium channels (IKr and IKs, 
red circles) are the most frequently affected ion channels in LQTS. Defect ion 
channels lead to a prolongation of action potential duration (lower left panel). 
Action potential prolongation is inhomogeneously distributed throughout the 
ventricles leading to dispersion of electrical repolarization (lower right panel).   
Dispersion of action potential repolarization can occur between apex and 
base i.e. longitudinally and transmurally (8, 9). Longest APD in LQTS models has 
been reported in endocardial Purkinje cells and in subendocardial to mid-
myocardial cells (M-cells), while shortest APD occurs in epicardial cells (5, 10). 
These transmural APD duration differences have been defined as transmural 
electrical dispersion (4). 
Life threatening ventricular arrhythmia occurring early in life is the gravest 
symptom of the LQTS. Genetic testing for LQTS has become more available and 
family screening has lead to a substantial amount of known individuals carrying an 
LQTS related mutation. However, the overall risk that adult asymptomatic 
mutation positive family members will experience arrhythmias during their 
lifetime is low and in these individuals QTc has failed to be a significant predictor 
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of outcome (11). Prophylactic treatment involves lifelong beta blocker therapy and 
decisions regarding preventive treatment is often challenging. Further risk 
stratification tools are needed.  
Left ventricular (LV) function has been considered to be normal in LQTS 
patients and echocardiography in these patients has traditionally been performed 
only to exclude additional heart diseases. There is, however, support for the 
assumption that prolonged action potential duration and electrical dispersion may 
cause wall motion abnormalities in these patients which can be assessed by 
echocardiography (12, 13).
Arrhythmogenic right ventricular cardiomyopathy 
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an 
inheritable, chronic and progressive cardiomyopathy and  is one of the leading 
causes of sudden unexpected cardiac death in previously healthy young individuals 
(14, 15). Prevalence has been estimated to be at least 1 in 1000 (15). 
Recent molecular genetic reports have revealed ARVC as mainly a 
desmosomal disease (16). Mutations in one of the 5 desmosomal or 3 extra 
desmosomal genes so far identified, lead to progressive loss of myocytes, followed 
by fibro-fatty replacement. Penetrance is age and gender dependent and the 
progressive clinical picture is highly variable (17).
Four clinical stages have been documented: An early concealed phase, 
overt electrical disorder, isolated right heart failure, and biventricular pump failure 
(15, 18, 19). Importantly, life-threatening arrhythmias can occur with only discrete 
or even absent myocardial structural changes (20). Risk stratification of ventricular 
arrhythmias and sudden cardiac death is therefore challenging.
Mechanisms for arrhythmias in early stages of ARVC are probably due  to 
dysfunction of desmosomal proteins and disturbed cell to cell coupling (21). In 
later stages of ARVC when structural abnormalities in the myocardium have 
developed, reentrant ventricular arrhythmias can occur in tissue with fibro fatty 
replacement. Therefore, electrical conduction disturbances with consequent 
electrical dispersion has been suggested as an important mechanism of ventricular 
arrhythmias (22, 23). 
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Patients after myocardial infarction
Patients after myocardial infarction (MI) are at high risk for cardiac 
arrhythmic events and sudden cardiac death (1). Currently, LV ejection fraction 
(EF) is the primary parameter used to select patients for implantable cardioverter 
defibrillator (ICD) therapy after a MI. Impaired EF is shown to be a marker of 
increased cardiovascular mortality and sudden cardiac death. However, EF has 
relatively low sensitivity to detect arrhythmic risk (24). A number of other 
diagnostic tests have been proposed to improve the accuracy for selection of 
patients for ICD therapy. Currently available data, however, are not adequate to 
routinely recommend additional risk-stratification methods for selection of patients 
for ICD therapy (25).
The presence of myocardial scar forms the substrate for malignant 
arrhythmias (26). Heterogeneity in scar tissue may create areas of slow conduction 
that generate the substrate for ventricular arrhythmia post-myocardial infarction 
(27). Electrical dispersion, including both activation time and refractoriness, in 
infarcted tissue is a known arrhythmogenic factor (7, 28-30). Electrical 
abnormalities may lead to distorted myocardial function (31). Therefore, regional 
differences in electrical properties may cause heterogeneity of myocardial 
contraction which can be recognized as myocardial dyssynchrony (32).  
Novel echocardiographic techniques; Tissue Doppler 
velocity and myocardial strain 
Minor degrees of myocardial contraction heterogeneity and subtle 
contraction dyssynchrony can be demonstrated by modern echocardiographic 
techniques including tissue Doppler imaging and myocardial strain (33, 34). 
During a cardiac cycle, apex is relatively fixed, while basis is moving towards 
apex in systole. Myocardial tissue movement produces high amplitude Doppler 
signals, but has low velocity compared to blood flow. Tissue Doppler imaging 
(TDI) echocardiography has been introduced as a method to quantify longitudinal 
cardiac motion in terms of tissue velocities (35, 36). In Paper 1, 
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tissue Doppler velocities were mainly used to assess timing of myocardial 
contraction.
Myocardial strain is a measure of deformation of a defined cardiac 
segment. Strain is defined as the fractional change of tissue length and is expressed 
as percent shortening (or lengthening) of a segment during systole (34, 37).  Strain 
by echocardiography has been demonstrated to be a more accurate tool for 
quantification of myocardial function compared to EF (38). Strain measurements 
were used in Paper 2-4.
In this thesis, tissue Doppler velocities and myocardial strain by 
echocardiography were used to accurately assess timing and function of 
myocardial contraction in patients with increased risk of ventricular arrhythmias. 
The hypotheses in this thesis were based on the assumption that arrhythmogenic 
electrical abnormalities will lead to mechanical alterations which can be assessed 
by TDI and strain echocardiography.
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Aims of the thesis 
General
To investigate if novel echocardiographic tools can improve risk 
stratification of life threatening ventricular arrhythmias in individuals at risk.  
Specific
1. We aimed to investigate if LQTS patients with prolonged APD have 
prolonged myocardial contraction duration which can be assessed by TDI 
and strain echocardiography. Furthermore, if LQTS patients have 
contraction heterogeneity assessed as mechanical dispersion and if 
mechanical dispersion can be a marker of ventricular arrhythmias. 
2. We aimed to investigate if there are regional contraction differences 
throughout the left ventricle in LQTS patients. We hypothesized that 
myocardial contraction is most prolonged in subendocardial myofibers in 
LQTS patients where longest APD has been reported. Furthermore, we 
aimed to investigate if inhomogeneous transmural contraction is related to 
risk of spontaneous arrhythmia.  
3. We aimed to investigate if heterogeneity in infarcted myocardial tissue 
leads to contraction heterogeneity assessed as mechanical dispersion which 
can be assessed by myocardial strain echocardiography. Furthermore, if 
mechanical dispersion in patients after myocardial infarction can predict 
ventricular arrhythmias and if global strain by echocardiography is a better 
marker of arrhythmias than EF in these patients.  
4. We aimed to investigate if ARVC patients have cardiac contraction 
heterogeneity assessed as mechanical dispersion which is associated with 
susceptibility to ventricular arrhythmias. Furthermore, if mechanical 
dispersion is present in ARVC mutation carriers in early stages of the 
disease where no structural alterations are visible.  
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Subjects  
Patients with long QT syndrome  
A total of 101 patients with molecularly defined LQTS were included in 
this thesis. Paper 1 included 73 of these LQTS patients. All patients were 
genotyped: 64 had LQT1 mutation (KCNQ1-gene), 26 LQT2 (HERG-gene), 1 
LQT3 (SCN5A-gene), 1 LQT5 (Mink-gene) and 9 were double mutation carriers 
(KCNQ1-gene) and had clinically Jervell and Lange-Nielsen syndrome with 
concomitant deafness. In all, 48 (48%) had a history of documented arrhythmia, 
syncope or cardiac arrest, while 53 (52%) were asymptomatic mutation carriers 
recruited by family cascade genetic screening. We did not include asymptomatic 
mutation carriers younger than 18 years of age because we regarded them too 
young to be classified as true asymptomatic. None of the LQTS patients were 
ventricularly paced or had structural heart disease of other origin.  
Patients with ICD after myocardial infarction 
85 post-MI patients fulfilling indications for ICD therapy were recruited 
from 4 university hospitals (St.Olavs Hospital, Trondheim, Ullevål University 
Hospital, Oslo, University Hospital Gasthuisberg, Leuven, Belgium and 
Rikshospitalet University Hospital, Oslo). All patients were included prospectively 
with echocardiographic examination performed during the hospitalization for ICD 
implantation. Inclusion criteria were prior MI and indication for ICD therapy 
according to primary or secondary prevention criteria. Exclusion criteria were 
atrial fibrillation, left bundle branch block, previous coronary artery bypass graft 
surgery and valve regurgitations greater than moderate. Arrhythmic events during 
follow up were defined as ventricular arrhythmias that required appropriate anti 
tachycardia pacing (ATP) or shock from the ICD.  
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Patients with ARVC  
Among 59 patients in the studygroup, 36 (61%) had symptomatic ARVC 
fulfilling 2010 International Task Force criteria (39), while 23 (39%) were 
asymptomatic mutation carriers, diagnosed by cascade genetic screening. ARVC 
related mutations were confirmed in 43 (73%) of all patients, (37 (86%) PKP2, 5 
(12%) DSP and 1 (2%) RYR2). Ventricular arrhythmias (sustained VT or VF) were 
documented in all 36 ARVC patients and 33 (92%) of these were treated with ICD 
in addition to medical antiarrhythmic therapy.  
Control groups 
Healthy individuals 
A total of 58 healthy individuals were recruited from the hospital staff in 
order to correspond with age and sex of the patient groups. All had normal ECG 
and echocardiography and used no medication. In Paper 1, 20 healthy controls 
participated, in Paper 2, 35, 23 participated in Paper 3 and 30 in Paper 4.
Individuals on beta-blocker therapy 
Since a substantial proportion of the LQTS patient group received beta 
blocker medication at inclusion time, 18 otherwise healthy individuals on beta-
blocker therapy were included for comparison in Paper 1. They were treated with 
beta-blockers for suspected angina pectoris from the referral institution ahead of an 
elective coronary angiography. They all showed a normal clinical examination, 
coronary angiography, ECG, QTc and echocardiography.
Patients with prior MI without ventricular arrhythmias 
From the outpatient clinic at Oslo University Hospital, Rikshospitalet we 
recruited 20 patients with prior MI for participation in Paper 3. None of these had 
arrhythmic events. Exclusion criteria were identical to the population with ICD 
after MI. 
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Methods
ECG
Twelve lead ECG was obtained at the time for echocardiographic 
examination. Bazett's formula was used for heart rate correction of the QT interval 
(40). QTc dispersion was measured as the difference between longest and shortest 
QTc interval in any of the 12 ECG leads (41).
Echocardiographic studies 
The echocardiographic studies were performed using Vivid 7 (GE 
Healthcare, Horten, Norway) and analyzed with software EchoPAC®, GE. By 
conventional 2 dimensional echocardiography, we assessed LV EF ad modum 
Simpson. All echocardiographic time measurements were corrected for heart rate 
using Bazett's formula (40). 
Tissue Doppler imaging 
In Paper 1, two dimensional TDI recordings of the LV were obtained from 
apical 4 chamber, 2 chamber and long axis views as previously described (37). 
Three cycles were analyzed and mean image frame rate obtained in these studies 
was 124±29 frames/s.  
Myocardial velocity parameters: 
From myocardial velocity curves, following parameters were assessed:  
1. Peak ejection velocity (Figure 2).
2. Peak myocardial velocity after aortic valve closure = post ejection 
velocity (PEV) (Figure 2).  
3. Maximum PEV in absolute value, negative or positive, was measured 
and the anatomical location was noted in each participant.  
4. Myocardial contraction duration was defined as the time from start of R 
on ECG to end of PEV (zero-crossing) if positive PEV was present. 
If no positive PEV was present, contraction duration was defined as the time from 
start of R on ECG to zero-crossing of the decreasing velocity slope in end-systole 
(Figure 2).
5. Contraction duration of the basal segment of the six LV wall positions 
was measured and the standard deviation of these values calculated as a parameter 
of mechanical dispersion of contraction (Figure 3).
Figure 2. Myocardial contraction duration by tissue Doppler imaging. 
Myocardial velocities from a healthy individual (left panel) and an LQTS patient 
(right panel). Contraction duration was defined as time from start of R on ECG to 
end of post ejection velocity (zero-crossing). (Eur Heart J. 2009). 
Figure 3. Myocardial mechanical dispersion by tissue Doppler imaging. 
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The left panel shows velocity curves from four different segments in a healthy 
individual in 4-chamber view. The right panel shows velocity curves from a 
symptomatic LQTS patient. White markers show the shortest and the 
longest contraction durations in each person. The difference in contraction 
duration is 0.03 s in the healthy individual and 0.12 s in the LQTS patient and is 
consistent with the mechanical dispersion of contraction (Eur Heart J. 2009). 
Strain by speckle tracking echocardiography 
Strain is defined as the fractional change of tissue length and is expressed 
in a dimensionless unit either as percent shortening (negative values) (Figure 4) or 
percent lengthening (positive values).  
In Paper 2, 3 and 4 strain measurements were obtained by speckle tracking 
echocardiography as previously described (38). Briefly, speckles are results of the 
ultrasound technique. The software algorithm tracks the speckles from frame to 
frame and calculates the distance between the speckles during the heart cycle. 
These distance measurements provide accurate assessment of myocardial 
contraction during the cardiac cycle. 2-D grayscale images were acquired in apical 
4 chamber, 2 chamber and long axis views. Figure 4 displays strain curves from a 
healthy individual.
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Figure 4. Speckle tracking longitudinal strain curves from 6 segments in apical 4 
chamber view from a healthy individual with synchronous ECG recording below. 
Segment contraction (shortening) starts during QRS and reaches maximum 
shortening (white vertical arrow) at the end of the ECG T-wave. 
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AVC (green vertical line) indicates timing of aortic valve closure.  In diastole, 
segment is lengthening. Global strain was defined as mean myocardial shortening 
from a 16 LV segments model. Contraction duration was defined as the time from 
ECG onset Q/onset R wave to maximum myocardial shortening (time lines). 
Mechanical dispersion was calculated as standard deviation of contraction 
duration from 16 LV segments. 
In Paper 2, we assessed longitudinal and circumferential strains. The 
addition of circumferential strain in Paper 2 was performed as an indirect measure 
of transmural differences in myocardial contraction. The subendocardium mainly 
consists of longitudinal myocardial fibers while the mid-myocardium mainly 
consists of circumferentially oriented fibers (42). Due to this myocardial fiber 
geometry, strain measurements are able to indirectly discriminate differences 
between subendocardial and mid-myocardial layers. Contraction durations by 
longitudinal strain therefore mainly measure subendocardial myofiber contraction 
while contraction durations by circumferential strain measure mid-mycoardial 
contraction. Considering this myocardial fiber orientation, we used differences in 
longitudinal and circumferential contraction duration as an indirect measure of 
transmural mechanical dispersion.   
We assessed the following parameters at frame rate of 76±18 frames/s:  
1. Maximum myocardial shortening (Figure 4).
2. Global strain, calculated as the average of longitudinal maximum 
myocardial shortening from 16 LV segments.  
3. Time from ECG onset Q (onset R wave if Q wave was absent) to 
maximum myocardial shortening defined as contraction duration (Figure 4).
4. Standard deviation of the 16 longitudinal measured and 6 circumferential 
measured contraction durations was calculated as parameters of mechanical 
dispersion.
5. Time difference between the longest and the shortest contraction 
duration was defined as delta contraction duration in longitudinal and 
circumferential directions.  
6. Transmural mechanical dispersion was expressed by the time difference 
in longitudinal and circumferential contraction durations of the 6 basal LV 
segments (Figure 5).  
Figure 5. Longitudinal (left panel) and circumferential (right panel) strain in a 
symptomatic LQTS patient by speckle tracking echocardiography. Longitudinal 
strain mainly measures subendocardial myofibers, while circumferential strain 
mainly measures mid-myocardial fibers.  Mean longitudinal strain was longer 
compared to mean circumferential strain in this symptomatic LQTS patient, 
indicating transmural mechanical dispersion. 
In post-MI patients in Paper 3, following parameters were assessed by 
longitudinal strain by speckle tracking technique with frame rate at 63±23 
frames/s:  
1. Contraction duration as the time from start of Q/R wave on ECG to 
maximum myocardial shortening (Figure 4)  
2. Mechanical dispersion was calculated from contraction durations from a 
16 LV segments model.  
3. Global LV strain was obtained by averaging all segmental values for 
maximum shortening in a 16 segment model (Figure 4).  
4. The difference between the longest and the shortest contraction duration 
in each individual was defined as delta contraction duration 
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In Paper 4, peak systolic myocardial strain by 2D speckle tracking 
echocardiography was assessed in 16 LV segments and averaged to LV global 
longitudinal strain in ARVC patients (Figure 4). Additionally, peak systolic strain 
from 3 right ventricular (RV) free wall segments was averaged as a measure of RV 
function (RV strain) (Figure 6). Contraction duration was measured as time from 
onset R on ECG to maximum LV and RV shortening by strain. Standard deviation 
of contraction duration was calculated as mechanical dispersion, in a 16 LV 
segment and a 6 RV segment model.  
Figure 6. Strain curves from a dilated right ventricle in an ARVC patient from 
apical 4 chamber view.  Vertical arrows indicate the timing of maximum 
myocardial shortening in each RV segment and are consistent with pronounced 
RV mechanical dispersion.
Reproducibility and feasibility 
Paper 1: The intra- and inter observer variability of PEV measurements 
demonstrated an intraclass correlation coefficient of 0.92 (95% CI 0.84-0.96) and 
0.79 (95% CI 0.68-0.86), respectively and for contraction duration measurements 
0.97 (95% CI 0.92- 0.99) and 0.92 (95% CI 0.72- 0.98) respectively.
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Paper 2:  Myocardial strain could be assessed in 98% of the myocardial 
segments in LQTS mutation carriers and in 94% of the subjects in the healthy 
individuals.  The primary analysis was done by a single observer and 
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repeated in a blinded fashion. For contraction duration intra-, inter observer and 
test retest intraclass correlation were 0.96, 0.96 and 0.87, respectively and for 
mechanical dispersion 0.98, 0.89, 0.79, respectively. The corresponding QTc and 
QTc dispersion test retest intraclass correlation were 0.82 and 0.67, respectively. 
Paper 3: Strain parameters could be assessed in 95% of the myocardial 
segments in the study group and in 91% of the subjects in the control group. Time 
measurements included 88% of the segments in the infarcted patients with ICD. 
Intra observer and inter observer variability were 0.98 and 0.98, respectively, for 
strain measurements and 0.86 and 0.81 for time measurements.  
Statistical analyses 
Continuous data were presented as mean ± standard deviation or as median 
(range). Comparisons of means were analyzed by unpaired t test or ANOVA with 
the Bonferroni correction for multiple comparisons (SPSS 15.0). For comparisons 
within the same patient, paired t test was used. Kruskal Wallis test was performed 
for non-parametric variables. Proportions were compared with the use of Chi 
square or Fisher’s exact test. Cox regression analysis was used in Paper 3 to 
identify predictors of the outcome arrhythmia requiring appropriate ICD treatment. 
Hazard ratios and 95% confidence intervals (CI) were calculated. The multivariate 
analysis was performed by including significant variables from the univariate 
model (p<0.05) in addition to age and EF which were forced in. A close 
relationship was observed between mechanical dispersion and delta contraction 
duration and therefore only dispersion was included in the multivariate analysis. 
Kaplan-Meier analysis was used to create freedom-from-arrhythmia survival 
curves. Receiver operating characteristics (ROC) analyses were performed in all 4 
papers. The value closest to the upper left corner of the ROC curve was used to 
define cut off value for optimal sensitivity and specificity for the ability of the 
parameters contraction duration and mechanical dispersion to identify arrhythmic 
events. Reproducibility was expressed as intraclass correlation coefficient. P-
values less than 0.05 were considered significant.
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Summary of results 
Paper 1 
LQTS mutation carriers (n=73) were compared with 20 healthy individuals 
and 18 otherwise healthy individuals on beta blocker therapy with respect to 
cardiac contraction duration and mechanical dispersion measured by tissue 
Doppler imaging.  
Contraction duration was significantly longer in symptomatic LQTS 
mutation carriers compared to asymptomatic carriers and healthy individuals 
(460±60ms vs. 400±60ms and 360±40ms, p<0.001). The correlation between 
contraction duration and QTc was significant (R=0.43, p<0.001). In contrast to 
healthy individuals, LQTS mutation carriers showed contraction durations that 
exceeded the time to aortic valve closure. Otherwise healthy individuals on beta-
blocker therapy did not have prolonged contraction duration compared to healthy 
individuals (380±40ms vs. 360±40ms, ns). Mechanical dispersion, assessed as 
standard deviation of contraction duration, was significantly greater in LQTS 
mutation carriers compared to healthy individuals (40±20ms vs. 14±13ms, 
p<0.001) and compared to otherwise healthy individuals on beta blocker therapy 
(40±20ms vs. 24±17ms, p=0.005). In addition, mechanical dispersion was 
significantly greater in symptomatic compared to asymptomatic LQTS mutation 
carriers (48±18ms vs. 31±19ms, p=0.001).  
A marked post ejection shortening velocity (PEV) was observed in LQTS 
mutation carriers and was significantly greater than PEV found in healthy 
individuals (1.8±1.4cm/s vs. -0.2±0.7cm/s, p<0.001). In addition, the maximum 
PEV in symptomatic LQTS mutation carriers was greater than in asymptomatic 
LQTS mutation carriers (2.3±1.3cm/s vs. 1.1±1.3cm/s, p=0.001).  
By ROC analysis, contraction duration identified mutation carriers with a 
history of cardiac events with better specificity and sensitivity than QTc did 
(Figure 7). 
Figure 7. ROC curves of cardiac events (documented arrhythmia, syncope or 
aborted cardiac arrest) in 64 single LQTS mutation carriers (33 symptomatic and 
31 asymptomatic). Myocardial contraction duration shows higher ability to 
identify cardiac events compared to QTc. Area under curve 0.77 (95% CI 0.65-
0.89) vs. 0.66 (95% CI 0.52-0.79).  
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Paper 2 
101 LQTS mutation carriers (53 asymptomatic and 48 symptomatic) were 
investigated by myocardial strain in longitudinal and circumferential directions in 
order to detect regional myocardial contraction abnormalities. 35 healthy 
individuals served as control group.
Symptomatic LQTS mutation carriers had longer QTc compared to 
asymptomatic mutation carriers (495±50ms vs. 460±30ms, p<0.001).  
Mean longitudinal contraction duration was longer in LQTS mutation 
carriers compared to healthy individuals (445±45ms vs. 390±40ms, p<0.001) and 
longer in symptomatic compared to asymptomatic LQTS mutation carriers 
(460±40ms vs. 425±45ms, p<0.001).  
In symptomatic LQTS patients, mean contraction duration measured by 
longitudinal strain was significantly longer compared to circumferential reflecting 
transmural dispersion (460±45ms vs. 445±45ms, p=0.008), indicating transmural 
mechanical dispersion. This time difference was present a majority of LV 
segments and most evident in LQT2 and patients with Jervell and Lange-Nielsen 
syndrome. In asymptomatic LQTS mutation carriers and healthy individuals there 
were no significant differences in mean contraction duration measured by 
longitudinal compared to circumferential strain (p=0.31 and p=0.99, respectively), 
indicating absence of transmural mechanical dispersion.  
Longitudinal mechanical dispersion was more pronounced in LQTS 
patients compared to healthy individuals (36±15ms vs. 20±7ms, p<0.001) (Figure 
8). In addition, mechanical dispersion was significantly greater in symptomatic 
LQTS mutation carriers compared to asymptomatic in longitudinal (45±13ms vs. 
27±12ms, p<0.001) and circumferential directions (46±22ms vs. 26±21ms, 
p<0.001).  QTc dispersion was prolonged in symptomatic LQTS mutation carriers 
compared to asymptomatic (56±23ms vs. 48±17ms, p=0.04). There was a 
moderate, but significant correlation between mechanical dispersion and QTc 
dispersion (R=0.30, p=0.007) 
As determined by ROC analysis, longitudinal mechanical dispersion could 
better discriminate between LQTS mutation carriers with and 
without cardiac events (syncope, documented arrhythmia, aborted cardiac arrest) 
compared to QTc (Area under the curve for mechanical dispersion 0.87 (95%CI 
0.79-0.94) versus QTc 0.71 (95%CI 0.61-0.81) (p<0.01). 
Figure 8. Myocardial strain curves from 6 different locations in a healthy 
individual (left panel) and a LQTS patient (right panel). White arrows indicate 
timing of maximum myocardial shortening. Mechanical dispersion was calculated 
as the standard deviation from 12 different contraction durations. The LQTS 
patient shows more pronounced mechanical dispersion compared to the healthy 
individual.
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Paper 3 
Mechanical dispersion was assessed in 44 post-MI patients with ICD 
according to primary prevention criteria and in 41 post-MI patients with ICD 
according to secondary prevention criteria. Thirty-eight (45%) ICD patients 
experienced one or more episodes with sustained VT or VF requiring appropriate 
ICD therapy (ATP or shock) while 47(55%) had no sustained arrhythmia during 
2.3(0.6,5.5) years of follow up. Post-MI patients without ICD indication (n=20) 
and healthy individuals (n=23) were included for comparison.  
Mechanical dispersion was significantly more pronounced in those with 
arrhythmias compared to those without (85±29ms vs. 56±13ms, p<0.001) (Figure 
9). By Cox regression, mechanical dispersion was a strong and independent 
predictor of arrhythmias requiring ICD therapy (per 10ms increase of mechanical 
dispersion: HR 1.25, 95% confidence interval (CI) 1.1 to 1.4, p<0.001). By Kaplan 
Meier analysis, ICD patients with mechanical dispersion >70ms showed more 
frequent arrhythmic events than ICD patients with dispersion <70ms (Log Rank 
test, p<0.001). In ICD patients with EF>35%, mechanical dispersion was more 
pronounced in those who experienced arrhythmia (n=22) compared to those 
without (n=21) (80± 27ms vs. 61±12ms, p=0.01). Control post MI patients without 
ICD indication had slightly pronounced mechanical dispersion compared to 
healthy individuals (45±15ms vs. 22±10ms, p<0.01).  
Global strain showed better LV function in those without recorded 
arrhythmias (-14.0±4.0% vs. -12.0±3.0%, p=0.05), while EF did not differ (44±8% 
vs. 41±5%, p=0.23). 
Figure 9. Mechanical dispersion by strain echocardiography in a healthy 
individual and ICD patients without and with follow up arrhythmias. 
Speckle tracking longitudinal strain curves in 4-chamber view from a healthy 
individual (left panel), a post-MI ICD patient without arrhythmic events (center 
panel) and a post-MI ICD patient with recurrent arrhythmias (right panel). White 
arrows indicate timing of maximum myocardial shortening in each segment. 
Myocardial shortening is reduced in the ICD patients and the timing of shortening 
is dispersed compared to the healthy individual. The dotted line represents the 
average myocardial shortening for each individual. SD = standard deviation of 
time to maximum myocardial shortening. (J Am Coll Cardiol Img 2010; 3:247-56) 
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Paper 4 
Mechanical dispersion and strain in RV and LV were assessed in 36 ARVC 
patients, in 23 asymptomatic ARVC mutation carriers and in 30 healthy 
individuals.
Mechanical dispersion was more pronounced in ARVC patients with 
arrhythmias in RV and LV compared to asymptomatic mutation carriers and 
healthy individuals (Table 1). Importantly, mechanical dispersion was more 
pronounced in asymptomatic mutation carriers compared to healthy individuals in 
both RV and LV, indicating sub clinical ventricular involvement. RV and LV 
strains were reduced in ARVC patients compared to asymptomatic mutation 
carriers and healthy individuals (Table 1). Reduced RV and LV strain were 
significantly correlated in ARVC patients, indicating biventricular disease 
(R=0.84, p<0.05). RV and LV function in asymptomatic mutation carriers were 
within normal range, but significantly reduced compared to healthy individuals.
Four study patients initially were admitted to hospital due to life 
threatening arrhythmias (2 with VF and 2 with VT).  Despite normal conventional 
echocardiographic and MRI findings at admittance, all 4 had significant increase 
in mechanical dispersion in RV (48±11ms) and LV (52±11ms) compared to 
healthy individuals (both p<0.001). Three of them had an ARVC related mutation 
and 1 patient progressed subsequently to typical ARVC phenotype. 
Table1. Echocardiographic results in 36 ARVC patients, 23 asymptomatic ARVC 
mutation carriers and 30 healthy individuals.  
Healthy 
individuals 
(n=30)
Asymptomatic 
mutation carriers 
(n=23)
ARVC patients 
with arrhythmias 
(n=36)
P
EF (%) 64±5 63±4 57±14* <0.01
LV strain (%) -23±2 -20±2* -16±5*·** <0.001
RV strain (%) -28±5 -24±5* -19±7*·** <0.001
LV Dispersion (ms) 22±8 42±13* 64±25*·** <0.001
RV Dispersion (ms) 15±8 33±20* 53±25*·** <0.001
Mean±SD. Right column shows P-values for ANOVA test. Flags for significance are
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Mean±SD. Right column shows P-values for ANOVA test. Flags for significance are obtained from the post 
hoc pair-wise comparison using the Bonferroni correction. *p<0.05 compared with healthy individuals. 
**p<0.01 compared with asymptomatic mutation carriers. ANOVA, analysis of variance; EF, ejection 
fraction; RV, right ventricular; LV, left ventricular.  
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Discussion
This thesis introduces new principles in risk assessment of life threatening 
arrhythmias in patients with susceptibility for ventricular arrhythmia. LQTS-, 
ARVC- and post-MI patients with recorded arrhythmias showed pronounced 
mechanical dispersion assessed by echocardiographic techniques. In all studies, 
mechanical dispersion was a marker of arrhythmic evens. These findings indicate 
that myocardial electrical abnormalities present in these patients may be visualized 
as mechanical dispersion by accurate echocardiographic techniques.  
Electromechanical interactions in LQTS  
As the QT interval on the surface ECG represents the summation of action 
potentials in ventricular myocytes, QT prolongation implies action potential 
prolongation in at least some portions of the ventricle. A prolongation of the action 
potential duration is associated with an increase in the tension developed by the 
ventricular muscle leading to a prolonged contraction (43-45). In Paper 1 and 2, 
prolonged contraction duration was demonstrated in LQTS mutation carriers 
compared to healthy individuals and in symptomatic LQTS mutation carriers 
compared to asymptomatic. The contraction duration in LQTS mutation carriers 
exceeded the time to aortic valve closure. This indicated myocardial contraction 
after aortic valve closure, which may be a result of an inhomogeneous end of 
contraction not sufficient to maintain the opening of the aortic valve.
These findings were in accordance with sporadic but consistent reports 
during the past 20 years that electrical alterations in LQTS patients have 
mechanical consequences (12, 13, 46, 47). The specific patterns of myocardial 
contraction abnormalities described in this thesis may depend on the concomitant 
electrical disorder in these patients.  
Mechanical dispersion in LQTS  
Findings from LQTS patients have implicated a specific role for dispersion 
of electrical repolarization in ventricular arrhythmogenesis (8, 48). Dispersion of 
repolarization can occur between apex and base i.e. longitudinally 
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and transmurally and facilitate the generation of Torsade de Pointes arrhythmia 
(8). The measurement of QT dispersion on ECG as an indicator of dispersion of 
ventricular repolarization was presented as a promising tool in risk stratification of 
arrhythmias two decades ago (49). However, the method has not achieved the 
clinical value as initially expected due to challenges in T-wave definition and poor 
reproducibility (50). QTc dispersion in this study showed significant differences 
between LQTS mutation carriers with and without arrhythmic events. The 
moderate but significant correlation to mechanical dispersion supported that our 
echocardiographic findings may reflect electrical dispersion. 
 With the methods presented in this thesis, we were able to quantify 
longitudinal (between apex and base) and inter regional mechanical dispersion 
(between interventricular septum, lateral wall, anterior and posterior wall). In 
Paper 2, we were also able to provide an indirect measure of mechanical 
transmural dispersion, when comparing duration of longitudinal strain 
(subendocardial fibers) with circumferential strain (mid-myocardial fibers). 
Contraction duration by longitudinal strain (subendocardial layers) was 
significantly longer than by circumferential strain (mid myocardial layers) in 
symptomatic LQTS patients. These findings indicate a transmural mechanical 
dispersion in symptomatic LQTS patients which was not present in asymptomatic 
and healthy individuals. These mechanical findings are in accordance with 
previous electrical LQTS models reporting longest APD in Purkinje cells and M 
cells which are located in the subendocardium and mid myocardium (5, 10, 51). 
Purkinje cells are found in the His bundle, bundle branches and cover much of the 
endocardium (51). The transmural mechanical dispersion presented in Paper 2 may 
represent the transmural electrical dispersion of repolarization which is shown to 
be present in LQTS models and which is suggested to be a strong arrhythmogenic 
factor (8). Despite the limited number of genotype subgroup participants, 
transmural mechanical dispersion was pronounced in LQT2 patients and patients 
with JLNS. These findings may indicate genotype specific differences in electrical 
dispersion and are in accordance with the higher arrhythmic risk in patients with 
these genotypes (2, 52).
In summary, Paper 1 and 2 demonstrated that mechanical dispersion can be 
assessed by TDI and strain echocardiography as regional differences in contraction 
duration throughout the LV. Importantly, prolonged and dispersed myocardial 
contraction was associated with a higher risk of cardiac arrhythmias in LQTS 
mutation carriers.  
Mechanical dispersion and LV function in infarcted tissue  
There is ample evidence from different cardiac disease models, including 
heart failure (53), ischemia (28) and infarction (29, 54) that increases in dispersion 
of conduction velocity result in susceptibility to arrhythmias (9, 53, 54). These 
electrical abnormalities will presumptively lead to changes in myocardial function. 
Assessing the extent of electrical dispersion in the individual patient has so far 
been difficult (53). In Paper 3, mechanical dispersion was pronounced in post-MI 
ICD patients with recurrent ventricular arrhythmias compared to ICD patients 
without further arrhythmias. These findings support the idea that tissue 
heterogeneity in and around scarred myocardium lead to a dispersed myocardial 
contraction and is associated with risk of arrhythmic events.  
In control post-MI patients with preserved EF and without arrhythmias, 
mechanical dispersion was significantly lower compared to ICD patients with 
recorded arrhythmias, and tended to be lower compared to ICD patients without 
arrhythmic events. These findings demonstrated presence of mechanical dispersion 
in all post-MI patients and support the assumption that the extent of mechanical 
dispersion is important in arrhythmogenesis.  
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Earlier echocardiographic studies have observed  that an EF of 40%
serves as the threshold for identifying high-risk individuals (55, 56). However, EF 
has reduced sensitivity in predicting sudden death; less than 50% of patients with 
prior MI who die suddenly have EF below 30% (24, 57). Speckle based strain has 
shown to be a robust technique for assessment of LV function and a recent study 
has demonstrated that speckle tracking strain is superior to EF for assessment of 
myocardial function post-MI (38). In Paper 3, global strain discriminated between 
those with and without arrhythmic events in post-MI patients with EF>35%. This 
finding suggests that global strain might become a useful tool for 
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risk stratification in post-MI patients with relatively preserved LV function. EF, 
however, failed to identify arrhythmic events in post-MI patients with EF>35%. 
Future trials should investigate if mechanical dispersion and global strain can be 
used to select additional patients for ICD therapy among the majority of post-MI 
patients with relatively preserved EF in whom current ICD indications fail.  
Mechanical dispersion and biventricular dysfunction in 
ARVC
Risk stratification of ventricular arrhythmias in so far asymptomatic ARVC 
mutation carriers is difficult. Paper 4 demonstrated that mechanical dispersion was 
closely related to ventricular arrhythmias in patients with ARVC.  Increased 
mechanical dispersion in both ventricles was present in asymptomatic mutation 
carriers, indicating sub clinical myocardial alterations. Importantly, pronounced 
mechanical dispersion was also present in individuals who had experienced 
arrhythmias in the early stages of ARVC and in whom no structural alterations 
assessed by conventional echocardiography and MRI could be assessed. These 
findings suggest that mechanical dispersion may be a marker of arrhythmic events 
and help risk stratification in so far asymptomatic ARVC mutation carriers. 
Mechanical dispersion and myocardial strains demonstrated subclinical myocardial 
involvement in these individuals. Longitudinal follow up studies are required to 
assess if these methods can provide added value in arrhythmia risk stratification in 
asymptomatic ARVC mutation carriers.  
Furthermore, Paper 4 demonstrated frequent and early LV involvement in 
ARVC which support recent reports of ARVC as a biventricular disease (58).  
Biventricular impairment is probably a result of biventricular ARVC affection, but 
mutual dependency of RV and LV hemodynamics may be considered. In patients 
with overt ARVC, strain echocardiography may be a useful tool for quantification 
of right and left sided myocardial dysfunction.  
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Mechanical dispersion in LQTS, ARVC and post-MI 
patients
In this thesis, mechanical dispersion was demonstrated in LQTS patients, 
ARVC patients and in post-MI patients and was shown to be a marker of recurrent 
ventricular arrhythmias. The mechanisms for arrhythmias in LQTS, ARVC and in 
infarcted myocardial tissue are different, but have similarities regarding electrical 
dispersion. In LQTS patients, inherited ion channel defects result in prolonged 
APD. Inhomogeneous prolongation of APD in LQTS result in dispersed electrical 
repolarization, which is regarded as a major arrhythmia mechanism. In ARVC 
patients, mechanisms of arrhythmias are probably stage dependent, but electrical 
dispersion has been considered to be of importance in early and later stages of the 
disease (22, 23). In post-MI patients delayed start of ventricular activation in 
scarred myocardium leads to a dispersed recovery of excitability (29), finally 
resulting in dispersed electrical repolarization. One might therefore speculate that 
electrical dispersion may be regarded as the final common pathway of arrhythmia 
mechanism in all three conditions.  
The extent of mechanical dispersion appeared most pronounced in post-MI 
patients, followed by ARVC patients and less pronounced in LQTS patients. These 
differences were probably a result of the concomitant contractile impairment in 
infarcted tissue and presence of fibrosis in ARVC which were not present in LQTS 
patients as confirmed in this thesis. Post-MI patients and ARVC patients had 
significantly impaired myocardial function, while LQTS patients had normal EF 
and strain amplitudes. Contractile impairment will pronounce mechanical 
dispersion. The ranges and values of mechanical dispersion which are related to 
increased arrhythmic risk will therefore not necessarily be interchangeable 
between different myocardial diseases.  
Methodology: Tissue velocities by Doppler and strain by 
speckle tracking echocardiography 
In Paper 1, TDI measurements were used for assessment of contraction 
duration and mechanical dispersion. A limitation of TDI is marked 
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angle dependency, which makes it sensitive to malalignment between the principle
direction of myocardial shortening and the Doppler beam. In order to avoid 
problems related to angle dependency of the TDI technique, we excluded velocity 
curves obtained from apical segments. TDI technique is appropriate for time 
measurements. The high temporal resolution facilitates high accuracy in time 
measurements. The reason for using TDI myocardial velocities in Paper 1 was that 
this technique is widely in use. However, the TDI velocity method in Paper 1 was 
not designed to distinctly quantify separate regions of the myocardium for 
comparison. In Paper 2-4, myocardial strain measurements were used. Myocardial 
strain measurements can identify myocardial dysfunction of more regional 
character, and can accurately assess myocardial shortening in a distinct part of the 
ventricle. Speckle tracking technique as used in these papers is attractive and 
robust in use. Compared to the TDI technique, speckle tracking is ultrasound beam 
angle independent and easier and faster to use. Reproducibility and feasibility 
studies in this thesis including velocity and strain measurements were satisfying.
This thesis shows that echocardiographic evaluation of mechanical 
dispersion can add important information in patients with susceptibility for 
ventricular arrhythmias. Importantly, mechanical dispersion should be used in 
addition to current risk stratification tools in order to include further patients for 
therapy. The studies in this thesis were not designed to provide results which could 
exclude patients from current therapy.    
Limitations
The association between mechanical dispersion and electrical dispersion 
should be studied in experimental studies.  
Paper 1 and 2 did not provide data that actually demonstrated that 
asymptomatic LQTS mutation carriers with prolonged contraction duration and 
pronounced mechanical dispersion were more likely to develop arrhythmias than 
those without. This requires prospective studies where asymptomatic untreated 
patients are followed for an adequate period of time, which is difficult for ethical 
reasons.
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Arrhythmia prediction by mechanical dispersion in post-MI patients in 
Paper 3 must be interpreted with respect to the fact that all patients fulfilled current 
guidelines for ICD therapy and may not be appropriate in patients not fulfilling 
current ICD indications. Further prospective trials including post-MI patients not 
fulfilling ICD indications are required.  
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Main conclusions 
Novel echocardiographic methods add important information in risk 
stratification of ventricular arrhythmias in patients at risk.  
1. LQTS patients showed prolonged myocardial contraction duration assessed 
with TDI velocities and strain echocardiography. LQTS patients had more 
pronounced mechanical dispersion compared to healthy individuals. LQTS 
patients with arrhythmias had more pronounced mechanical dispersion than 
asymptomatic LQTS mutation carriers. Mechanical dispersion was superior 
to QTc in identifying arrhythmic events and may provide added value in risk 
stratification of LQTS mutation carriers.  
2. Symptomatic LQTS mutation carriers had longer contraction duration in the 
subendocardial layer compared to the mid layer of the ventricular wall, 
indicating transmural mechanical dispersion which was not present in 
asymptomatic mutation carriers and in healthy individuals. Transmural 
mechanical dispersion was evident in patients with LQT2 and Jervell and 
Lange-Nilsen syndrome and associated with ventricular arrhythmias.  
3. Post-MI patients at risk for cardiac arrhythmias had increased myocardial 
mechanical dispersion by strain echocardiography. Mechanical dispersion 
was a strong and independent predictor of arrhythmic events in post-MI 
patients. LV global strain discriminated between post-MI patients with and 
without arrhythmic events in those with relatively preserved EF, while EF 
did not differ. Mechanical dispersion and global strain may be useful for 
including more patients after MI for ICD therapy. 
4. Mechanical dispersion was pronounced in ARVC patients and was related to 
ventricular arrhythmias. The findings were present in both right and left 
ventricle supporting that ARVC is a biventricular disease. Mechanical 
dispersion was present in asymptomatic mutation carriers with no signs of 
the disease on MRI or traditional echocardiography. Follow up studies are 
needed to evaluate mechanical dispersion as a risk stratification tool in 
ARVC mutation carriers. 
39
References
 1.  Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, et al. 
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular 
arrhythmias and the prevention of sudden cardiac death: a report of the American 
College of Cardiology/American Heart Association Task Force and the 
European Society of Cardiology Committee for Practice Guidelines (Writing 
Committee to Develop Guidelines for Management of Patients With Ventricular 
Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol
2006;48:e247-e346.
 2.  Priori SG, Schwartz PJ, Napolitano C, Bloise R, Ronchetti E, Grillo M, et al. 
Risk stratification in the long-QT syndrome. N Engl J Med 2003;348:1866-1874. 
 3.  Killeen MJ, Sabir IN, Grace AA, Huang CLH. Dispersions of repolarization and 
ventricular arrhythmogenesis: Lessons from animal models. Prog Biophys Mol 
BiolIn Press, Corrected Proof. 
 4.  Yan GX, Shimizu W, Antzelevitch C. Characteristics and distribution of M cells 
in arterially perfused canine left ventricular wedge preparations. Circulation
1998;98:1921-1927.
 5.  Yan GX, Antzelevitch C. Cellular basis for the normal T wave and the 
electrocardiographic manifestations of the long-QT syndrome. Circulation
1998;98:1928-1936.
 6.  Antzelevitch C, Shimizu W, Yan GX, Sicouri S, Weissenburger J, Nesterenko 
VV, et al. The M cell: its contribution to the ECG and to normal and abnormal 
electrical function of the heart. J Cardiovasc Electrophysiol 1999;10:1124-1152. 
 7.  Janse MJ, Wit AL. Electrophysiological mechanisms of ventricular arrhythmias 
resulting from myocardial ischemia and infarction. Physiol Rev 1989;69:1049-
1169.
 8.  Antzelevitch C, Yan GX, Shimizu W. Transmural dispersion of repolarization 
and arrhythmogenicity: the Brugada syndrome versus the long QT syndrome. J
Electrocardiol 1999;32 Suppl:158-165. 
 9.  Olsson SB, Shiwen Y, Amlie JP. Dispersion of repolarisation. State of the Art.
New York 10504, USA: Futura Publishing Company.; 2000. 
 10.  Dun W, Boyden PA. The Purkinje cell; 2008 style. J Mol Cell Cardiol
2008;45:617-624.
40
 11.  Goldenberg I, Moss AJ, Bradley J, Polonsky S, Peterson DR, McNitt S, et al. 
Long-QT syndrome after age 40. Circulation 2008;117:2192-2201. 
 12.  Nador F, Beria G, De Ferrari GM, Stramba-Badiale M, Locati EH, Lotto A, et al. 
Unsuspected echocardiographic abnormality in the long QT syndrome. 
Diagnostic, prognostic, and pathogenetic implications. Circulation
1991;84:1530-1542.
 13.  De Ferrari GM, Nador F, Beria G, Sala S, Lotto A, Schwartz PJ. Effect of 
calcium channel block on the wall motion abnormality of the idiopathic long QT 
syndrome. Circulation 1994;89:2126-2132. 
 14.  Thiene G, Nava A, Corrado D, Rossi L, Pennelli N. Right ventricular 
cardiomyopathy and sudden death in young people. N Engl J Med 1988;318:129-
133.
 15.  Sen-Chowdhry S, Morgan RD, Chambers JC, McKenna WJ. Arrhythmogenic 
cardiomyopathy: etiology, diagnosis, and treatment. Annu Rev Med
2010;61:233-253.
 16.  Xu T, Yang Z, Vatta M, Rampazzo A, Beffagna G, Pillichou K, et al. Compound 
and Digenic Heterozygosity Contributes to Arrhythmogenic Right Ventricular 
Cardiomyopathy 
1. J Am Coll Cardiol 2010;55:587-597. 
 17.  Dalal D, James C, Devanagondi R, Tichnell C, Tucker A, Prakasa K, et al. 
Penetrance of mutations in plakophilin-2 among families with arrhythmogenic 
right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 2006;48:1416-
1424.
 18.  Basso C, Thiene G, Corrado D, Angelini A, Nava A, Valente M. 
Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or 
myocarditis? Circulation 1996;94:983-991. 
 19.  Sen-Chowdhry S, Syrris P, Ward D, Asimaki A, Sevdalis E, McKenna WJ. 
Clinical and genetic characterization of families with arrhythmogenic right 
ventricular dysplasia/cardiomyopathy provides novel insights into patterns of 
disease expression. Circulation 2007;115:1710-1720. 
 20.  Sen-Chowdhry S, Morgan RD, Chambers JC, McKenna WJ. Arrhythmogenic 
cardiomyopathy: etiology, diagnosis, and treatment. Annu Rev Med
2010;61:233-253.
 21.  Saffitz JE. Arrhythmogenic cardiomyopathy and abnormalities of cell-to-cell 
coupling. Heart Rhythm 2009;6:S62-S65. 
 22.  Amlie JP. Dispersion of repolarization. A basic electrophysiological mechanism 
behind malignant arrhythmias. Eur Heart J 1997;18:1200-1202. 
41
 23.  Turrini P, Corrado D, Basso C, Nava A, Bauce B, Thiene G. Dispersion of 
ventricular depolarization-repolarization: a noninvasive marker for risk 
stratification in arrhythmogenic right ventricular cardiomyopathy. Circulation
2001;103:3075-3080.
 24.  Buxton AE, Lee KL, Hafley GE, Pires LA, Fisher JD, Gold MR, et al. 
Limitations of ejection fraction for prediction of sudden death risk in patients 
with coronary artery disease: lessons from the MUSTT study. J Am Coll Cardiol
2007;50:1150-1157.
 25.  Passman R, Kadish A. Sudden death prevention with implantable devices. 
Circulation 2007;116:561-571. 
 26.  Zipes DP, Wellens HJ. Sudden cardiac death. Circulation 1998;98:2334-2351. 
 27.  Verma A, Marrouche NF, Schweikert RA, Saliba W, Wazni O, Cummings J, et 
al. Relationship between successful ablation sites and the scar border zone 
defined by substrate mapping for ventricular tachycardia post-myocardial 
infarction. J Cardiovasc Electrophysiol 2005;16:465-471. 
 28.  Han J, Moe GK. Nonuniform recovery of excitability in ventricular muscle. Circ
Res 1964;12:44-60. 
 29.  Vassallo JA, Cassidy DM, Kindwall KE, Marchlinski FE, Josephson ME. 
Nonuniform recovery of excitability in the left ventricle. Circulation
1988;78:1365-1372.
 30.  Endresen K, Amlie JP, Forfang K, Simonsen S, Jensen O. Monophasic action 
potentials in patients with coronary artery disease: reproducibility and electrical 
restitution and conduction at different stimulation rates. Cardiovasc Res
1987;21:696-702.
 31.  Nagueh SF. Mechanical dyssynchrony in congestive heart failure: diagnostic and 
therapeutic implications. J Am Coll Cardiol 2008;51:18-22. 
 32.  Yu CM, Lin H, Zhang Q, Sanderson JE. High prevalence of left ventricular 
systolic and diastolic asynchrony in patients with congestive heart failure and 
normal QRS duration. Heart 2003;89:54-60. 
 33.  Yu CM, Sanderson JE, Marwick TH, Oh JK. Tissue Doppler imaging a new 
prognosticator for cardiovascular diseases. J Am Coll Cardiol 2007;49:1903-
1914.
 34.  Reisner SA, Lysyansky P, Agmon Y, Mutlak D, Lessick J, Friedman Z. Global 
longitudinal strain: a novel index of left ventricular systolic function. J Am Soc 
Echocardiogr 2004;17:630-633. 
 35.  Wilkenshoff UM, Sovany A, Wigstrom L, Olstad B, Lindstrom L, Engvall J, et 
al. Regional mean systolic myocardial velocity estimation by real-
42
time color Doppler myocardial imaging: a new technique for quantifying 
regional systolic function. J Am Soc Echocardiogr 1998;11:683-692. 
 36.  Edvardsen T, Urheim S, Skulstad H, Steine K, Ihlen H, Smiseth OA. 
Quantification of left ventricular systolic function by tissue Doppler 
echocardiography: added value of measuring pre- and postejection velocities in 
ischemic myocardium. Circulation 2002;105:2071-2077. 
 37.  Edvardsen T, Gerber BL, Garot J, Bluemke DA, Lima JA, Smiseth OA. 
Quantitative assessment of intrinsic regional myocardial deformation by Doppler 
strain rate echocardiography in humans: validation against three-dimensional 
tagged magnetic resonance imaging. Circulation 2002;106:50-56. 
 38.  Gjesdal O, Helle-Valle T, Hopp E, Lunde K, Vartdal T, Aakhus S, et al. 
Noninvasive Separation of Large, Medium, and Small Myocardial Infarcts in 
Survivors of Reperfused ST-Elevation Myocardial Infarction: A Comprehensive 
Tissue Doppler and Speckle-Tracking Echocardiography Study. Circ Cardiovasc 
Imaging 2008;1:189-196. 
 39.  Marcus FI, McKenna WJ, Sherrill D, Basso C, Bauce B, Bluemke DA, et al. 
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia:
proposed modification of the task force criteria. Circulation 2010;121:1533-
1541.
 40.  Bazett H.C. An analysis of the time-relations of electrocardiography. Heart
1920;7:353-370.
 41.  Priori SG, Napolitano C, Diehl L, Schwartz PJ. Dispersion of the QT interval. A 
marker of therapeutic efficacy in the idiopathic long QT syndrome. Circulation
1994;89:1681-1689.
 42.  Sengupta PP, Korinek J, Belohlavek M, Narula J, Vannan MA, Jahangir A, et al. 
Left ventricular structure and function: basic science for cardiac imaging. J Am 
Coll Cardiol 2006;48:1988-2001. 
 43.  Morad M, Trautwein W. The effect of the duration of the action potential on 
contraction in the mammalian heart muscle. Pflugers Arch Gesamte Physiol 
Menschen Tiere 1968;299:66-82. 
 44.  Arreola J, Dirksen RT, Shieh RC, Williford DJ, Sheu SS. Ca2+ current and 
Ca2+ transients under action potential clamp in guinea pig ventricular myocytes. 
Am J Physiol 1991;261:C393-C397. 
 45.  Morad M, Orkand RK. Excitation-concentration coupling in frog ventricle: 
evidence from voltage clamp studies. J Physiol 1971;219:167-189. 
 46.  Nakayama K, Yamanari H, Otsuka F, Fukushima K, Saito H, Fujimoto Y, et al. 
Dispersion of regional wall motion abnormality in patients with long QT 
43
syndrome. Heart 1998;80:245-250. 
 47.  Savoye C, Klug D, Denjoy I, Ennezat PV, Le Tourneau T, Guicheney P, et al. 
Tissue Doppler echocardiography in patients with long QT syndrome. Eur J 
Echocardiogr 2003;4:209-213. 
 48.  Shimizu W, Ohe T, Kurita T, Takaki H, Aihara N, Kamakura S, et al. Early 
afterdepolarizations induced by isoproterenol in patients with congenital long 
QT syndrome. Circulation 1991;84:1915-1923. 
 49.  Barr CS, Naas A, Freeman M, Lang CC, Struthers AD. QT dispersion and 
sudden unexpected death in chronic heart failure. Lancet 1994;343:327-329. 
 50.  Kautzner J, Yi G, Camm AJ, Malik M. Short- and long-term reproducibility of 
QT, QTc, and QT dispersion measurement in healthy subjects. Pacing Clin 
Electrophysiol 1994;17:928-937. 
 51.  Zipes DP. Genesis of Cardiac Arrhythmias: Electrophysiological considerations. 
In: Braunwald E, ed. Heart Disease. 4 ed. Philadelphia: W.B. Saunders 
company; 1992. p. 588-627. 
 52.  Schwartz PJ, Spazzolini C, Crotti L, Bathen J, Amlie JP, Timothy K, et al. The 
Jervell and Lange-Nielsen syndrome: natural history, molecular basis, and 
clinical outcome. Circulation 2006;113:783-790. 
 53.  Tomaselli GF, Zipes DP. What causes sudden death in heart failure? Circ Res
2004;95:754-763.
 54.  Spragg DD, Akar FG, Helm RH, Tunin RS, Tomaselli GF, Kass DA. Abnormal 
conduction and repolarization in late-activated myocardium of dyssynchronously 
contracting hearts. Cardiovasc Res 2005;67:77-86. 
 55.  Bigger JT, Jr., Fleiss JL, Kleiger R, Miller JP, Rolnitzky LM. The relationships 
among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 
2 years after myocardial infarction. Circulation 1984;69:250-258. 
 56.  Greenberg H, McMaster P, Dwyer EM, Jr. Left ventricular dysfunction after 
acute myocardial infarction: results of a prospective multicenter study. J Am Coll 
Cardiol 1984;4:867-874. 
 57.  Stecker EC, Vickers C, Waltz J, Socoteanu C, John BT, Mariani R, et al. 
Population-based analysis of sudden cardiac death with and without left 
ventricular systolic dysfunction: two-year findings from the Oregon Sudden 
Unexpected Death Study. J Am Coll Cardiol 2006;47:1161-1166. 
 58.  Kjaergaard J, Hastrup SJ, Sogaard P, Chen X, Bay NH, Kober L, et al. Advanced 
quantitative echocardiography in arrhythmogenic right ventricular 
cardiomyopathy. J Am Soc Echocardiogr 2007;20:27-35. 

I

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
CLINICAL RESEARCH
Arrhythmias
Left ventricular mechanical dispersion by tissue
Doppler imaging: a novel approach for identifying
high-risk individuals with long QT syndrome
Kristina Hermann Haugaa1, Thor Edvardsen1, Trond P. Leren2, Jon Michael Gran3,
Otto A. Smiseth1, and Jan P. Amlie1*
1Department of Cardiology, Rikshospitalet University Hospital, University of Oslo, N-0027 Oslo, Norway; 2Medical Genetics Laboratory, Department of Medical Genetics,
Rikshospitalet University Hospital, Oslo, Norway; and 3Department of Biostatistics, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway
Received 24 April 2008; revised 28 August 2008; accepted 29 September 2008; online publish-ahead-of-print 21 October 2008
See page 253 for the editorial comment on this article (doi:10.1093/eurheartj/ehn587)
Aims The aim of this study was to investigate whether prolonged and dispersed myocardial contraction duration assessed
by tissue Doppler imaging (TDI) may serve as risk markers for cardiac events (documented arrhythmia, syncope, and
cardiac arrest) in patients with long QT syndrome (LQTS).
Methods
and results
Seventy-three patients with genetically conﬁrmed LQTS (nine double- and 33 single-mutation carriers with previous
cardiac events and 31 single-mutation carriers without events) were studied. Myocardial contraction duration was
prolonged in each group of LQTS patients compared with 20 healthy controls (P, 0.001). Contraction duration
was longer in single-mutation carriers with previous cardiac events compared with those without (0.46+0.06 vs.
0.40+ 0.06 s, P ¼ 0.001). Prolonged contraction duration could better identify cardiac events compared with cor-
rected QT (QTc) interval in single-mutation carriers [area under curve by receiver-operating characteristic analysis
0.77 [95% conﬁdence interval (95% CI) 0.65–0.89] vs. 0.66 (95% CI 0.52–0.79)]. Dispersion of contraction was more
pronounced in single-mutation carriers with cardiac events compared with those without (0.048+ 0.018 vs.
0.031+ 0.019 s, P ¼ 0.001).
Conclusion Dispersion of myocardial contraction assessed by TDI was increased in LQTS patients. Prolonged contraction dur-
ation was superior to QTc for risk assessment. These new methods can easily be implemented in clinical routine and
may improve clinical management of LQTS patients.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
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Introduction
The long QT syndrome (LQTS) is a genetic disorder characterized
by prolonged ventricular repolarization that predisposes to life-
threatening arrhythmias.1 The pathophysiology behind the arrhyth-
mias in LQTS is not precisely deﬁned. Possible mechanisms include
early after-depolarizations (EADs) and dispersion of myocardial
repolarization.
Fifty years after its initial description,2–4 approaches for risk
stratiﬁcation are insufﬁciently deﬁned. Risk stratiﬁcation today is
based on history of syncope, genotype, gender, and corrected
QT (QTc) interval.1,5 Prolonged QTc is a marker of prolonged
action potential duration which is associated with a prolonged
left ventricular (LV) contraction.6–8 Electrocardiogram (ECG)
has limited abilities to detect regional differences in LV electrical
pattern. A relationship between motion abnormalities of the LV
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assessed by echocardiography and syncope or cardiac arrest in
LQTS patients was ﬁrst indicated by Schwartz and colleagues.9,10
Tissue Doppler imaging (TDI) has been established as a clinical
method for the quantiﬁcation of regional myocardial function.11
The diagnostic value of this new modality has not been previously
described in LQTS patients.
The objective of this study was to determine whether myocardial
velocities, time-intervals, or strains by TDI could be a tool for iden-
tifying high-risk individuals in LQTS patients. High risk was deﬁned as
patients with a previous cardiac event, i.e. documented arrhythmia,
syncope, or cardiac arrest. Our hypothesis was that prolonged
action potentials will cause a prolonged myocardial contraction
that can be assessed by TDI. Furthermore, we hypothesized that
myocardial mechanical dispersion can be assessed as heterogeneity
in the regional myocardial contraction duration by TDI.
Methods
Long QT syndrome patients
Seventy-three patients with molecularly deﬁned LQTS were included
in this study (Figure 1). None of the LQTS patients had structural
heart disease of other origin or were ventricularly paced. All 73
LQTS mutation carriers were genotyped: 44 LQT1, 18 LQT2, 1
LQT3, 1 LQT5, and nine double-mutation carriers. Double-mutation
carriers were considered a separate category and were analysed
separately.
Long QT syndrome single-mutation carriers
Sixty-four patients were single-mutation carriers of an
LQTS-associated mutation. Of the single-mutation carriers, 33 (52%)
had a history of documented arrhythmia, syncope, or cardiac arrest,
here deﬁned as ‘symptomatic’. All symptomatic and three asympto-
matic single-mutation carriers received therapy with beta-blockers
(n ¼ 36). In addition to beta-blocker therapy, three single-mutation
carriers were treated with an ICD and three with atrial pacemaker.
In addition, six single-mutation carriers were studied with ECG and
echocardiography but deemed ineligible for inclusion. One of these six
was an LQT1 patient who received chemotherapy owing to malignant
disease and developed cardiomyopathy with reduced LV function. Five
asymptomatic mutation carriers ,15 years of age were ineligible for
inclusion. We could not exclude future cardiac events in these
young individuals and their status as asymptomatic in this study
would therefore be inaccurate.
Long QT syndrome double-mutation carriers,
Jervell and Lange-Nielsen syndrome
Nine patients were double-mutation carriers of an LQTS-associated
mutation and had clinically Jervell and Lange-Nielsen syndrome
(JLNS) with additional deafness. All JLNS patients had experienced
repeated cardiac events and were treated with beta-blockers. In
addition, one JLNS patient was treated with left sympathetic denerva-
tion, two with an ICD, and three with atrial pacemaker.
Control groups
Healthy individuals
Twenty healthy individuals were age- and sex-matched and recruited
from hospital staff. All had normal clinical examination, ECG, QTc,
and echocardiography.
Individuals on beta-blocker therapy
Since 64% of the LQTS patients were on beta-blocker therapy, we
included 18 individuals on beta-blocker therapy for comparison.
They were treated with beta-blockers for suspected angina pectoris
from the referral institution ahead of an elective coronary angiography.
They were included in our beta-blocker control group after ﬁndings of
a normal coronary angiography at our hospital. In addition, normal
ﬁndings were required for the clinical examination, ECG, QTc, and
echocardiography. Beta-blocker treatment was discontinued in all
these patients after the examination at our hospital.
Figure 1 Algorithm of study participants. The groups of healthy individuals and individuals on beta-blocker therapy represent the control
groups.
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Written informed consent was given by all participants. The study
was approved by the Regional Committee for Medical Research Ethics.
Electrocardiogram
Twelve-lead ECG was obtained in all participants, either before or
after echocardiography. The QT interval was corrected for heart
rate using Bazett’s formula.12
Echocardiographic studies
The echocardiographic studies were performed using Vivid 7 (GE
Healthcare, Horten, Norway) and analysed with commercially available
software (EchoPACw, GE). By conventional 2D echocardiography,
we assessed LV ejection fraction ad modum Simpson. Systolic time
interval was assessed by Doppler ﬂow velocity measurement as the
time from start of R on ECG to aortic valve closure.
Tissue Doppler imaging
Two-dimensional TDI recording of the LV was obtained from the
basal and mid-segments from apical four-chamber, two-chamber, and
long-axis views. Three cycles were analysed and the image frame
rate obtained in this study was 124+29 frames/s. The following
parameters from TDI were assessed:
(i) Peak ejection velocity.
(ii) Peak myocardial velocity after aortic valve closure—post-ejection
velocity (PEV). PEV was deﬁned as the peak of the upstroke of
the biphasic spike after ejection. In individuals without post-
systolic shortening, this spike can occur below the zero line
(Figure 2).
(iii) Maximum PEV in absolute value, negative or positive, was
measured and the anatomical location was noted in each
participant.
(iv) Myocardial contraction duration was measured in the basal septal
segment and deﬁned as the time from start of R on ECG to end
of PEV (zero-crossing) if positive PEV was present. If no positive
PEV was present, contraction duration was deﬁned as the time
from start of R on ECG to zero-crossing of the decreasing
velocity slope in end-systole (Figure 2).
(v) Contraction duration of the basal segment of the six LV wall pos-
itions was measured and the standard deviation of these values
calculated as a parameter of mechanical dispersion of contraction
(Figure 3).
(vi) In diastole, we measured the time from start of R to onset of E0
and peak E0.
(vii) Contraction duration was measured in strain traces as the time
from start of R on ECG to peak negative strain (Figure 2).
Efforts were made to ensure good image quality in each patient. TDI
parameters could be assessed in 98% of the myocardial segments in
LQTS mutation carriers and in 94% of the subjects in the other
groups. The primary analysis was done unblinded by a single observer
and repeated in a blinded fashion 4 months later (K.H.H.). All analyses
were repeated by an independent observer (T.E.), blinded to patient
identity and other data. The authors had full access to the data and
take responsibility for its integrity. All authors have read and agree
to the manuscript as written.
Statistical analyses
Data were presented as mean+ standard deviation. Comparisons of
means were analysed by ANOVA with the Bonferroni post hoc correc-
tion for multiple comparisons (SPSS 15.0). Receiver-operating charac-
teristic (ROC) curves were constructed to determine the sensitivity
and speciﬁcity of the parameters—QTc, myocardial contraction dur-
ation, and PEV—to identify cardiac events (documented arrhythmia,
syncope, or cardiac arrest) in LQTS single-mutation carriers. For con-
traction duration and PEV, the optimal cut-offs were deﬁned as the
value of the ROC curve which was closest to the upper left corner
(Figure 4). The reliability of the cut-off values was validated using boot-
strap resampling (n ¼ 1000),13 and 95% conﬁdence intervals (95% CIs)
based on bootstrap percentiles were presented. The statistical soft-
ware package R (version 2.5.1) was used for bootstrap analysis. For
QTc, we used the established cut-off value of 0.46 s.14 For the area
under the ROC curve, 95% CIs were presented. Reproducibility was
expressed as intraclass correlation coefﬁcient for single measures.
For all statistical analyses, P-values were two-sided, with results less
than 0.05 considered signiﬁcant.
Figure 3 Myocardial mechanical dispersion by tissue Doppler
imaging. The left panels show velocity curves from four different
segments in a healthy individual in four-chamber (upper left) and
apical long-axis views (lower left). The right panels show velocity
curves from a symptomatic long QT syndrome patient. White
markers show the shortest and the longest contraction durations
in each person. The difference in contraction duration is 0.03 s in
the healthy individual and 0.12 s in the long QT syndrome patient
and is consistent with the mechanical dispersion of contraction.
Figure 2 Myocardial contraction duration by tissue Doppler
imaging. Myocardial velocities (upper panels) and strains (lower
panels) from a healthy individual (left) and a long QT syndrome
patient (right).
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Results
All groups of LQTS mutation carriers were comparable with
healthy individuals with respect to age and heart rate (Table 1).
The QTc was prolonged in each of the LQTS groups compared
with the control groups. EF and peak ejection velocity, as
markers of systolic function, were normal in all LQTS groups, in
healthy individuals and in individuals on beta-blocker therapy
(Table 1).
Echocardiographic analysis by tissue
Doppler imaging
Contraction duration was assessed in both myocardial velocity and
strain traces with consistent results.
Long QT syndrome single-mutation carriers
Contraction duration was signiﬁcantly longer in symptomatic
LQTS single-mutation carriers compared with asymptomatic car-
riers and healthy individuals (P ¼ 0.001) (Table 1). In contrast to
healthy individuals, LQTS mutation carriers showed contraction
durations that exceeded the time to aortic valve closure. Patients
on beta-blocker therapy did not have prolonged contraction dur-
ation. Therefore, the prolonged contraction duration in LQTS
mutation carriers could not be attributed to the use of beta-
blocker medication. Mechanical dispersion, assessed as standard
deviation of contraction duration, was signiﬁcantly greater in
LQTS single-mutation carriers compared with healthy individuals
(P, 0.001) and compared with individuals on beta-blocker therapy
(P, 0.001). In addition, mechanical dispersion was signiﬁcantly
greater in symptomatic compared with asymptomatic single-mutation
carriers (P¼ 0.001). The correlation between contraction duration
and QTc was signiﬁcant (R ¼ 0.43, P, 0.001).
A marked PEV was observed in LQTS mutation carriers and was
signiﬁcantly greater than PEV found in healthy individuals (Figure 2,
Table 1). In addition, the maximum PEV in symptomatic LQTS
single-mutation carriers was greater than that in asymptomatic
LQTS mutation carriers (P ¼ 0.001). The maximum PEV was
most often localized in the posterior part of the LV septum (n ¼
34), but was also found in the anterior part of the septum (n ¼
17), in the anterior wall (n ¼ 12), in the lateral wall (n ¼ 9), and
in the posterior wall (n ¼ 1) of the LV.
The onset of the E0 was delayed in symptomatic LQTS single-
mutation carriers compared with asymptomatic mutation carriers
and control subjects. Age-corrected E0-wave velocities were
lower in symptomatic than in asymptomatic mutation carriers
[7.9+ 1.9 vs. 8.9+1.9 cm/s; P ¼ 0.02 (Univariate Analysis of
Variance)].
Subgroup analysis of LQT1 and LQT2 patients (data not pre-
sented) did not show signiﬁcant differences in the echocardio-
graphic parameters.
We wanted to explore the incremental value provided by echo-
cardiography in LQTS mutation carriers. JLNS patients (double
mutation) were considered a separate category and not necessarily
representative of the more common patients with a single
mutation. Therefore, we constructed ROC curves for LQTS
single-mutation carriers exclusively (n ¼ 64). By ROC analysis,
contraction duration identiﬁed single-mutation carriers with a
history of cardiac events with better speciﬁcity and sensitivity
than QTc did (Figure 4). QTc 0.46 s showed a sensitivity of
70% (95% CI 67–88) and a speciﬁcity of 50% (95% CI 40–61)
to identify single-mutation carriers with a history of events. Con-
traction duration identiﬁed single-mutation carriers with a history
of events with a sensitivity of 79% (95% CI 68–87) and a speciﬁcity
of 74% (95% CI 62–83) with an optimal cut off value of 0.44 s
(95% CI by bootstrapping 0.41–0.46). Importantly, contraction
duration was prolonged in all six symptomatic single-mutation car-
riers that exhibited QTc shorter than 0.46 s. Optimal cut-off value
for PEV was 1.65 cm/s (95% CI by bootstrapping 1.24–2.23) and
demonstrated a sensitivity of 70% (95% CI 58–79) and a speciﬁcity
of 68% (95% CI 55–78) for a history of cardiac events in single-
mutation carriers by ROC analysis.
Long QT syndrome double-mutation carriers
QTc was markedly prolonged in double-mutation carriers com-
pared with all other groups (P, 0.001) (Table 1). Contraction dur-
ation was prolonged and PEV augmented compared with healthy
individuals and asymptomatic single-mutation carriers. Mechanical
dispersion was longer than in healthy individuals, but not signiﬁ-
cantly different from single-mutation carriers.
The intra- and interobserver variabilities of PEV measurements
demonstrated an intraclass correlation coefﬁcient of 0.92 (95%
CI 0.84–0.96) and 0.79 (95% CI 0.68–0.86), respectively, and for
contraction duration measurements of 0.97 (95% CI 0.92–0.99)
and 0.92 (95% CI 0.72–0.98), respectively.
Figure 4 Receiver-operating characteristic curves of cardiac
events (documented arrhythmia, syncope, or aborted cardiac
arrest) in 64 single long QT syndrome mutation carriers (33
symptomatic and 31 asymptomatic). Myocardial contraction dur-
ation shows higher sensitivity and speciﬁcity for cardiac events
compared with corrected QT interval. Area under curve 0.77
(95% CI 0.65–0.89) vs. 0.66 (95% CI 0.52–0.79).
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Discussion
The present study demonstrated that analyses of tissue Doppler
velocities added important information in patients with LQTS. Pro-
longed contraction duration showed better speciﬁcity and sensi-
tivity than QTc as a marker of cardiac events and therefore
provided added value in risk assessment in LQTS mutation car-
riers. The contraction duration showed greater heterogeneity in
LQTS mutation carriers than in controls, reﬂecting dispersion of
myocardial contraction, presumably caused by electrical dispersion
of repolarization. LQTS mutation carriers showed a marked
increase in PEV, indicating myocardial shortening after aortic
valve closure. These ﬁndings were associated with a history of
cardiac events.
Possible mechanisms
In the normal heart, several mechanisms regulate myocyte repolar-
ization. As the QT interval on the surface ECG represents the
summation of action potentials in ventricular myocytes, QT pro-
longation implies action potential prolongation in at least some
portions of the ventricle. A prolongation of the action potential
duration is associated with an increase in the tension developed
by the ventricular muscle, leading to a prolonged contraction.6–8
In this study, the prolonged contraction in LQTS mutation carriers
was assessed by TDI.
Action potential prolongation can lead to the development of
early EADs, which are oscillations in the membrane potential
before repolarization is complete. EADs may result in a second
contraction and lead to ectopic beats if occurring in a substantial
part of the myocardium.15 Triggered upstrokes from EADs are a
likely initiating mechanism for torsade de pointes ventricular tachy-
cardia.16–18 The prolonged contraction duration and the augmen-
ted PEV in LQTS mutation carriers could represent the mechanical
equivalent of an electrical EAD as proposed by De Ferrari et al.10
This is consistent with the ﬁnding that symptomatic LQTS
mutation carriers had greater PEV than asymptomatic mutation
carriers. EADs may be present at subthreshold levels in LQTS
mutation carriers also in basal conditions, without leading to
arrhythmias but causing contraction prolongation and PEV.
In the majority of our LQTS mutation carriers, we found the
greatest magnitude of the PEV in basal and mid-LV septal
regions. Previous reports have demonstrated that action potentials
of the mid-myocardial cells (M-cells) prolong more than epicardial
or endocardial in response to a lowering of heart rate or to action
potential-prolonging agents.19 A prolonged action potential leads
to a higher risk of EAD.15 M-cells have been identiﬁed in the inter-
ventricular septum and in the anterior and lateral walls.20 The
localization of the reported M-cells matched the regions of the
greatest PEV in our LQTS patients. Therefore, we speculated
that PEV and prolonged contraction assessed by TDI could be a
result of the prolonged action potentials in these M-cells that
are known to have the longest action potential duration.
A possible mechanism of arrhythmia in LQTS patients is
increased dispersion of repolarization.21 Dispersion of repolariza-
tion may be localized between two different ventricular regions
and as a transmural phenomenon.22,23 The measurement of
QTc and QT dispersion as indicators of ventricular repolarization
prolongation and dispersion have been widely used during the last
two decades.24 However, identiﬁcation of the end of the T-wave is
difﬁcult and measurements of dispersion by ECG have modest
reproducibility.25 The TDI method has the ability to measure
detailed time intervals in different regions of the LV. Our study
clearly demonstrated that the dispersion of mechanical contraction
can be assessed by TDI, as a regional difference in contraction dur-
ation throughout the LV. Furthermore, that mechanical dispersion
was more pronounced in symptomatic compared with asympto-
matic LQTS patients.
Double-mutation carriers, JLNS patients, represent the most
severe clinical phenotype and were therefore analysed separately
in this study. The presence of two mutations (JLNS) is associated
with higher risk of cardiac events and more widespread current
loss.26 In our study, these facts were supported by a more pro-
longed contraction duration in a greater number of cardiac seg-
ments in JLNS patients compared with single-mutation carriers.
Standard deviation of contraction duration was therefore lower
in the JLNS patients. Pronounced prolongation of contraction dur-
ation may indicate that EADs are the most likely mechanism for
arrhythmia in JLNS patients.
The contraction duration in LQTS mutation carriers exceeded
the time to aortic valve closure. This indicated myocardial contrac-
tion after aortic valve closure, which may be a result of an inhomo-
geneous end of contraction not sufﬁcient to maintain the opening
of the aortic valve. If the dispersion of contraction reﬂects the
electrical dispersion of repolarization, a major arrhythmogenic
factor present in LQTS mutation carriers can be shown by
echocardiography.
A prolonged myocardial contraction will lead to inhomogeneous
and delayed onset of the E0 wave. Furthermore, an inhomogeneous
onset of diastolic lengthening will cause reduced E0 amplitude and
prolonged duration of E0. These assumptions were conﬁrmed in
our study that showed delayed onset of E0, reduced amplitude of
the E0, and prolonged E deceleration time. These ﬁndings imply
an impairment of diastolic function in a number of symptomatic
LQTS mutation carriers.
Previous studies
Echocardiography has traditionally been used to exclude structural
heart disease in LQTS patients. However, Nador et al. presented
an echocardiographic study which showed speciﬁc ventricular
wall abnormalities in 42 LQTS patients.9 Using M-mode technique,
they demonstrated the occurrence of a slow contraction in the late
myocardial thickening phase. Further they demonstrated a dip in
the later part of contraction followed by a second anterior move-
ment of the endocardium producing a double-peak image. Interest-
ingly, their ﬁndings were associated with a greater probability of
syncope or cardiac arrest. These ﬁndings are conﬁrmed in our
study. We showed that prolonged contraction duration and
increased PEV, which give a similar double-peak pattern, are associ-
ated with cardiac events. Another study has shown mechanical
abnormality by M-mode technique in LQTS patients.27 Their ﬁnd-
ings were attributed to mechanical dispersion possibly caused
by electrical dispersion of repolarization. A recent case report
indicated mechanical dysfunction in a patient with extreme
QT prolongation.28 A recent study showed myocardial velocity
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abnormalities in 10 LQTS patients.29 Our study conﬁrms these
ﬁndings using a new modality of echocardiography. We believe
that TDI measurements may be an easier and more objective
way of quantifying abnormal regional motion than M-mode echo-
cardiography. The study by Nador et al. was followed by a study
giving calcium channel blockers to 10 LQTS patients.10 Verapamil
abolished the wall motion abnormality, suggesting that sympto-
matic LQTS patients may have an abnormal increase in the intra-
cellular calcium concentration before relaxation has completed,
possibly linked to an EAD, and that the contraction abnormality
may be the mechanical equivalent of an EAD.
Post-systolic shortening after aortic valve closure, which is
similar but not identical to PEV, has been demonstrated in ischae-
mic myocardium30,31 and may also occur in healthy individuals.32
PEV in ischaemic heart disease is of greater magnitude compared
with PEV in healthy individuals, and a coexisting reduction in ejec-
tion velocity is obligate.32 PEV can even be negative if post-systolic
shortening is missing in healthy individuals.32,33 The LQTS mutation
carriers had normal systolic ejection velocities and ejection frac-
tion. Thus, the elevated PEV in LQTS mutation carriers was not
considered to be a result of earlier cardiac arrests with concomi-
tant myocardial ischaemia.
Clinical implications
QTc is the most rational parameter for screening patients with
unexplained syncope or cardiac arrest. In known LQTS patients,
risk stratiﬁcation is based on the occurrence of previous
syncope, genotype, gender, and QTc.1 The recent development
from family cascade genetic screening has brought us numerous
LQTS mutation carriers with normal QTc, who would have
been undiagnosed before the genetic era. These asymptomatic
mutation carriers demonstrate neither clinical symptoms nor pro-
longed QTc. Nevertheless, they have increased risk of ventricular
arrhythmia and sudden cardiac death. It is a clinical challenge to
decide whether these asymptomatic mutation carriers should
receive prophylactic treatment or not. Assessment of myocardial
contraction duration may add important information in risk strati-
ﬁcation in LQTS mutation carriers when QTc is normal or mildly
prolonged. Our data showed that myocardial contraction duration
had higher sensitivity and speciﬁcity for a history of cardiac events
than QTc. Importantly, in all symptomatic mutations carriers that
QTc failed to identify, contraction duration by echocardiography
was prolonged (0.44 s).
Our study did not provide data that actually demonstrated that
asymptomatic LQTS mutation carriers with prolonged contraction
duration and elevated PEV were more likely to develop arrhyth-
mias than those without. This requires a prospective study in
which asymptomatic untreated patients are followed for an ade-
quate period of time, which is difﬁcult for ethical reasons. Never-
theless, we propose that TDI should become part of the routine
clinical evaluation for LQTS mutation carriers. The myocardial
contraction duration is relatively simple to obtain and has excellent
reproducibility for inter and intra-observations.
Limitations
Prolonged contraction duration by strain in this study was highly sig-
niﬁcant as a risk parameter for cardiac events. However, the results
assessed by myocardial velocities were signiﬁcantly associated with
cardiac events and therefore we preferred velocity to strain
measurements since the reproducibility of this method is superior.34
Circumferential and radial strains were not analysed in this study.
A limitation of TDI is marked angle dependency, which makes
it sensitive to mal-alignment between the principal direction of
myocardial shortening and the Doppler beam. Owing to less
angle dependency, time interval assessment provided by TDI is a
better reproducible parameter than measurements of velocity
amplitudes.
The association between myocardial mechanical and electrical
dispersion in LQTS mutation carriers should be studied in experi-
mental studies.
Conclusion
This study showed that TDI can be of important value in risk stra-
tiﬁcation of LQTS mutation carriers. Mechanical dispersion of
myocardial contraction assessed by TDI was increased in LQTS
patients. Prolonged myocardial contraction duration and augmen-
ted PEV were better related to cardiac events compared with
QTc. Therefore, we propose that these novel parameters might
be assessed in the management of LQTS patients.
Acknowledgements
We thank Are Hugo Pripp and Odd O. Aalen for statistical assist-
ance. We thank the funders and the patients and control subjects
who participated.
Funding
This work was supported by Inger and John Fredriksen’s Foundation
and the South-Eastern Norway Regional Health Authority. Funding
to pay the Open Access publication charges for this article was pro-
vided by Prof. Jan P. Amlie, University of Oslo.
Conﬂict of interest: none declared.
References
1. Priori SG, Schwartz PJ, Napolitano C, Bloise R, Ronchetti E, Grillo M, Vicentini A,
Spazzolini C, Nastoli J, Bottelli G, Folli R, Cappelletti D. Risk stratiﬁcation in the
long-QT syndrome. N Engl J Med 2003;348:1866–1874.
2. Jervell A, Lange-Nielsen F. Congenital deaf-mutism, functional heart disease with
prolongation of the Q-T interval and sudden death. Am Heart J 1957;54:59–68.
3. Romano C, Gemme G, Pongiglione R. Rare cardiac arrhythmias of the pediatric
age. II. Syncopal attacks due to paroxysmal ventricular ﬁbrillation. Presentation
of 1st case in Italian pediatric literature. Clin Pediatr (Bologna) 1963;45:656–683.
4. Ward OC. A new familial cardiac syndrome in children. J Ir Med Assoc 1964;54:
103–106.
5. Hofman N, Wilde AA, Kaab S, van Langen I, Tanck MW, Mannens MM,
Hinterseer M, Beckmann BM, Tan HL. Diagnostic criteria for congenital long
QT syndrome in the era of molecular genetics: do we need a scoring system?
Eur Heart J 2007;28:575–580.
6. Morad M, Trautwein W. The effect of the duration of the action potential on con-
traction in the mammalian heart muscle. Pﬂugers Arch Gesamte Physiol Menschen
Tiere 1968;299:66–82.
7. Arreola J, Dirksen RT, Shieh RC, Williford DJ, Sheu SS. Ca2þ current and Ca2þ
transients under action potential clamp in guinea pig ventricular myocytes. Am J
Physiol 1991;261:C393–C397.
8. Morad M, Orkand RK. Excitation–concentration coupling in frog ventricle: evi-
dence from voltage clamp studies. J Physiol 1971;219:167–189.
9. Nador F, Beria G, De Ferrari GM, Stramba-Badiale M, Locati EH, Lotto A,
Schwartz PJ. Unsuspected echocardiographic abnormality in the long QT syn-
drome. Diagnostic, prognostic, and pathogenetic implications. Circulation 1991;
84:1530–1542.
K.H. Haugaa et al.336
10. De Ferrari GM, Nador F, Beria G, Sala S, Lotto A, Schwartz PJ. Effect of calcium
channel block on the wall motion abnormality of the idiopathic long QT syn-
drome. Circulation 1994;89:2126–2132.
11. Edvardsen T, Urheim S, Skulstad H, Steine K, Ihlen H, Smiseth OA. Quantiﬁcation
of left ventricular systolic function by tissue Doppler echocardiography: added
value of measuring pre- and postejection velocities in ischemic myocardium.
Circulation 2002;105:2071–2077.
12. Bazett HC. An analysis of the time-relations of electrocardiography. Heart 1920;7:
353–370.
13. Efron B, Tibshirani R. Bootstrap methods for standard errors, conﬁdence
intervals and other methods of statistical accuracy. Stat Sci 1986;1:54–77.
14. Goldman MJ. Principles of Clinical Electrocardiography. 8th ed. Lange Medical;
1973.
15. January CT, Riddle JM. Early afterdepolarizations: mechanism of induction and
block. A role for L-type Ca2þ current. Circ Res 1989;64:977–990.
16. el-Sherif N, Zeiler RH, Craelius W, Gough WB, Henkin R. QTU prolongation and
polymorphic ventricular tachyarrhythmias due to bradycardia-dependent early
afterdepolarizations. Afterdepolarizations and ventricular arrhythmias. Circ Res
1988;63:286–305.
17. Clusin WT. Calcium and cardiac arrhythmias: DADs, EADs, and alternans. Crit Rev
Clin Lab Sci 2003;40:337–375.
18. Kannankeril PJ, Roden DM. Drug-induced long QT and torsade de pointes: recent
advances. Curr Opin Cardiol 2007;22:39–43.
19. Shimizu W, Antzelevitch C. Effects of a K(þ) channel opener to reduce trans-
mural dispersion of repolarization and prevent torsade de pointes in LQT1,
LQT2, and LQT3 models of the long-QT syndrome. Circulation 2000;102:
706–712.
20. Yan GX, Shimizu W, Antzelevitch C. Characteristics and distribution of M cells in
arterially perfused canine left ventricular wedge preparations. Circulation 1998;98:
1921–1927.
21. Kuo CS, Atarashi H, Reddy CP, Surawicz B. Dispersion of ventricular repolariza-
tion and arrhythmia: study of two consecutive ventricular premature complexes.
Circulation 1985;72:370–376.
22. Ueda N, Zipes DP, Wu J. Epicardial but not endocardial premature stimulation
initiates ventricular tachyarrhythmia in canine in vitro model of long QT syn-
drome. Heart Rhythm 2004;1:684–694.
23. Antzelevitch C, Shimizu W. Cellular mechanisms underlying the long QT syn-
drome. Curr Opin Cardiol 2002;17:43–51.
24. Barr CS, Naas A, Freeman M, Lang CC, Struthers AD. QT dispersion and sudden
unexpected death in chronic heart failure. Lancet 1994;343:327–329.
25. Kautzner J, Yi G, Camm AJ, Malik M. Short- and long-term reproducibility of QT,
QTc, and QT dispersion measurement in healthy subjects. Pacing Clin Electrophy-
siol 1994;17:928–937.
26. Schwartz PJ, Spazzolini C, Crotti L, Bathen J, Amlie JP, Timothy K, Shkolnikova M,
Berul CI, Bitner-Glindzicz M, Toivonen L, Horie M, Schulze-Bahr E, Denjoy I. The
Jervell and Lange-Nielsen syndrome: natural history, molecular basis, and clinical
outcome. Circulation 2006;113:783–790.
27. Nakayama K, Yamanari H, Otsuka F, Fukushima K, Saito H, Fujimoto Y, Emori T,
Matsubara H, Uchida S, Ohe T. Dispersion of regional wall motion abnormality in
patients with long QT syndrome. Heart 1998;80:245–250.
28. Vyas H, O’Leary PW, Earing MG, Cetta F, Ackerman MJ. Mechanical dysfunction
in extreme QT prolongation. J Am Soc Echocardiogr 2007; doi:10.1016.
29. Savoye C, Klug D, Denjoy I, Ennezat PV, Le Tourneau T, Guicheney P, Kacet S.
Tissue Doppler echocardiography in patients with long QT syndrome. Eur J
Echocardiogr 2003;4:209–213.
30. Skulstad H, Edvardsen T, Urheim S, Rabben SI, Stugaard M, Lyseggen E, Ihlen H,
Smiseth OA. Postsystolic shortening in ischemic myocardium: active contraction
or passive recoil? Circulation 2002;106:718–724.
31. Azevedo CF, Amado LC, Kraitchman DL, Gerber BL, Osman NF, Rochitte CE,
Edvardsen T, Lima JA. Persistent diastolic dysfunction despite complete systolic
functional recovery after reperfused acute myocardial infarction demonstrated
by tagged magnetic resonance imaging. Eur Heart J 2004;25:1419–1427.
32. Voigt JU, Lindenmeier G, Exner B, Regenfus M, Werner D, Reulbach U,
Nixdorff U, Flachskampf FA, Daniel WG. Incidence and characteristics of segmen-
tal postsystolic longitudinal shortening in normal, acutely ischemic, and scarred
myocardium. J Am Soc Echocardiogr 2003;16:415–423.
33. Edvardsen T, Aakhus S, Endresen K, Bjomerheim R, Smiseth OA, Ihlen H. Acute
regional myocardial ischemia identiﬁed by 2-dimensional multiregion tissue
Doppler imaging technique. J Am Soc Echocardiogr 2000;13:986–994.
34. Urheim S, Edvardsen T, Torp H, Angelsen B, Smiseth OA. Myocardial strain by
Doppler echocardiography. Validation of a new method to quantify regional
myocardial function. Circulation 2000;102:1158–1164.
LV mechanical dispersion by TDI 337
II

Arrhythmia/Electrophysiology
Transmural Differences in Myocardial Contraction in
Long-QT Syndrome
Mechanical Consequences of Ion Channel Dysfunction
Kristina Hermann Haugaa, MD; Jan P. Amlie, MD, PhD; Knut Erik Berge, MD, PhD;
Trond P. Leren, MD, PhD; Otto A. Smiseth, MD, PhD; Thor Edvardsen, MD, PhD
Background—Long-QT syndrome (LQTS) is characterized by prolonged myocardial action potential duration. The longest
action potential duration is reported in the endomyocardium and midmyocardium. Prolonged action potential duration
in LQTS may cause prolonged cardiac contraction, which can be assessed by strain echocardiography. We hypothesized
that myocardial contraction is most prolonged in subendocardial myofibers in LQTS patients and that inhomogeneous
transmural contraction is related to the risk of spontaneous arrhythmia.
Methods and Results—We included 101 genotyped LQTS mutation carriers and 35 healthy individuals. A history of
cardiac arrhythmias was present in 48 mutations carriers, and 53 were asymptomatic. Myocardial contraction duration
was assessed by strain echocardiography as time from the ECG Q wave to peak strain in 16 LV segments. Strain was
assessed along the longitudinal axis, predominantly representing subendocardial fibers, and along the circumferential
axis, representing midmyocardial fibers. Mean contraction duration was longer in LQTS mutation carriers compared
with healthy individuals (44545 versus 39040 milliseconds; P0.001) and longer in symptomatic compared with
asymptomatic LQTS mutation carriers (46040 versus 42545 milliseconds; P0.001). Contraction duration by
longitudinal strain was longer than by circumferential strain in symptomatic LQTS patients (46045 versus 44545
milliseconds; P0.008) but not in asymptomatic patients and healthy individuals, indicating transmural mechanical
dispersion. This time difference was present in a majority of LV segments and was most evident in patients with LQT2
and the Jervell and Lange-Nielsen syndrome.
Conclusion—Contraction duration in symptomatic LQTS mutation carriers was longer in the subendocardium than in the
midmyocardium, indicating transmural mechanical dispersion, which was not present in asymptomatic and healthy
individuals. (Circulation. 2010;122:1355-1363.)
Key Words: echocardiography  long QT syndrome  torsade de pointes  transthoracic echocardiography
 arrhythmia
The long-QT syndrome (LQTS) is due to inherited cardiacion channel defects and predisposes to life-threatening
ventricular arrhythmias and sudden cardiac death. Its preva-
lence has been estimated as 1 in 2000.1 LQTS-related ion
channels defects lead to prolonged cardiac action potential
duration (APD). The degree of action potential prolongation
and dispersion in timing of action potential repolarization
have been considered the major mechanisms behind the
ventricular arrhythmias in these patients. Earlier invasive
studies have indicated that the duration of the cardiac action
potential is not homogeneous throughout the myocardium in
either normal or genetically altered myocardial tissue.2,3 The
longest APD in LQTS models has been reported in endocar-
dial Purkinje cells and in subendocardial to midmyocardial
cells (M cells).4,5 Transmural differences in APD have been
considered to be of major importance in arrhythmogenesis in
LQTS patients.6 However, it has been challenging to assess
APD and dispersion in patients. Attempts to estimate action
potential dispersion in terms of QT dispersion have not been
clinically useful.7
Editorial see p 1353
Clinical Perspective on p 1363
Left ventricular (LV) function has been considered normal
in LQTS patients. There is, however, support for the assump-
tion that subtle electric changes may cause mechanical
dysfunction. Nador et al8 and De Ferrari et al9 have reported
wall motion abnormalities in LQTS patients. We recently
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reported prolonged myocardial contraction duration and pro-
nounced mechanical dispersion assessed by echocardiograph-
ic velocity measurements in patients with LQTS,10 and these
mechanical abnormalities were associated with a higher risk
of cardiac arrhythmias. These results supported that the
electric mechanisms for arrhythmia in LQTS may be trans-
lated into mechanical contraction abnormalities, including
prolongation and dispersion of myocardial contraction
duration.
Myocardial strain measurements have been proven to be
superior for assessment of regional LV function.11,12 The
subendocardium consists mainly of longitudinal myocardial
fibers, whereas the midmyocardium consists mainly of cir-
cumferentially oriented fibers.13 As a result of this myocardial
fiber geometry, strain measurements are able to indirectly
discriminate between transmural contraction differences (ie,
differences between subendocardial and midmyocardial
layers).
We hypothesized that myocardial contraction is inhomo-
geneously prolonged throughout the LV in LQTS patients
and that the longest contraction duration is located in the
subendocardium where the longest APD has been reported.
Furthermore, we wanted to investigate whether the heteroge-
neity of prolonged contraction is related to specific genotypes
and the risk for spontaneous arrhythmia in LQTS patients.
Methods
LQTS Mutation Carriers
A total of 101 genotyped LQTS mutation carriers were included in
this study. Sixty-four patients were heterozygous for a mutation in
the LQT1 locus and 26 in the LQT2 locus. Only 1 patient was
heterozygous for a mutation in the LQT3 locus and 1 in the LQT5
locus. A relatively high proportion of the study patients (n9) were
homozygotes or compound heterozygotes for mutations in the LQT1
locus (Jervell and Lange Nielsen syndrome [JLNS]). In all, 48 (48%)
had a history of documented arrhythmia, syncope, or cardiac arrest,
defined here as symptomatic, and 53 (52%) were asymptomatic
mutation carriers who were recruited from family cascade genetic
screening. -Blocker medications at the time of the examination
used in the study were metoprolol succinate in 37 patients (11347
mg/d), timolol in 7 patients (153 mg/d), propranolol in 6 patients
(188106 mg/d), and bisoprolol (100 mg/d) in 2 patients. In
addition to -blocker therapy, 6 mutation carriers were treated with
an implantable cardioverter-defibrillator and 3 with an atrial pace-
maker. One JLNS patient was also treated with left sympathetic
denervation. None of the LQTS patients had structural heart disease
of other origin. We did not include asymptomatic mutation carriers
18 years of age because we regarded them as too young to be
classified as truly asymptomatic.
Control Group
Healthy individuals from the hospital staff (n35) with age and sex
corresponding to the patients were recruited as a control group for
the echocardiographic measurements. ECG, heart rate correction of
the QT interval (QTc), and echocardiography showed normal find-
ings in all healthy individuals.
Written informed consent was given by all study participants. The
study was approved by the Regional Committee for Medical Re-
search Ethics.
Electrocardiography
Twelve-lead ECG was obtained at the time of echocardiographic
examination. The Bazett formula was used for QTc.14 QTc disper-
sion was measured as the difference between longest and shortest
QTc intervals in any of the 12 ECG leads.15,16
Echocardiographic Studies
The echocardiographic studies were performed on a Vivid 7 (GE
Healthcare, Horten, Norway). Data were analyzed with EchoPAC
(GE Healthcare). LV ejection fraction was assessed with the Simp-
son method from 2-dimensional echocardiography.
Figure 1. Longitudinal myocardial strain
curves from a healthy individual in the
apical 4-chamber view. Vertical arrow
indicates the amplitude of maximum
myocardial shortening in the septal basal
segment (yellow strain curve). Contrac-
tion duration was deﬁned as the time
from the Q wave or start of the R wave
on the ECG to maximum myocardial
shortening of each strain curve (horizon-
tal arrows). The SD of contraction dura-
tions from 16 LV segments was calcu-
lated as mechanical dispersion. AVC
indicates aortic valve closure.
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Myocardial Strain Measurements
We assessed longitudinal and circumferential strains by the speckle
tracking technique17 with a frame rate of 7618 frames per second.
Three cardiac cycles were analyzed.
We assessed the following parameters from myocardial strain:
maximum myocardial shortening (Figure 1); global strain calculated
as the average of longitudinal maximum myocardial shortening from
16 LV segments; time from ECG onset of the Q wave (onset of the
R wave if the Q wave was absent) to maximum myocardial
shortening defined as contraction duration (Figure 1); SD of the 16
longitudinally measured and 6 circumferentially measured contrac-
tion durations calculated as parameters of mechanical dispersion;
time difference between the longest and shortest contraction dura-
tions defined as delta contraction duration in the longitudinal and
circumferential directions; and transmural mechanical dispersion
expressed by the time difference in longitudinal and circumferential
contraction durations of the 6 basal LV segments (Figure 2).
Because tissue Doppler imaging (TDI) had higher temporal
resolution (12928 frames per second) compared with speckle
tracking measurements, TDI recordings of the LV were obtained
from the apical 4-chamber, 2-chamber, and long-axis views as
previously described.10
Heart rate was recorded at time of echocardiographic examination,
and all echocardiographic time measurements were corrected for
heart rate with the Bazett formula.14 Myocardial strain could be
assessed in 98% of the myocardial segments in LQTS mutation
carriers and in 94% of the segments in the healthy individuals. The
primary analysis was done by a single observer and repeated in a
blinded fashion. For contraction duration, intraobserver, interob-
server, and test-retest intraclass correlations were 0.96, 0.96, and
0.87, respectively; for mechanical dispersion, they were 0.98, 0.89,
and 0.79, respectively. The corresponding QTc and QTc dispersion
test-retest intraclass correlations were 0.82 and 0.67, respectively.
Statistical Analyses
Continuous data are presented as meanSD or as median (range).
Comparisons of means between groups of patients were performed
by unpaired Student t test (SPSS 15.0, SPSS Inc, Chicago, Ill). The
paired t test was used for all comparisons within the same patient.
Comparisons of proportions were performed by the Fisher exact test.
Receiver-operating characteristic (ROC) curves were created for
longitudinal mechanical dispersion and QTc to determine the dis-
crimination of these parameters, ie, the ability to distinguish between
LQTS mutation carriers with and without cardiac events (docu-
mented arrhythmia, syncope, or cardiac arrest). The optimal cutoff
value for mechanical dispersion was defined as the value from the
ROC curve closest to the top left corner. The sensitivity and
specificity for the optimal cutoff value were reported. For QTc, the
established cutoff value of 460 milliseconds was used.18 The area
under the ROC curve (AUC) was calculated for both parameters, and
comparison between AUCs19 was performed with the Analyze-it
software. For all statistical analyses, P values were 2 sided. Values
of P0.05 were considered statistically significant.
Results
Myocardial Function in LQTS Patients
Clinical characteristics and echocardiographic data are pre-
sented in Table 1. Age and heart rate were similar in LQTS
Figure 2. Transmural mechanical dispersion in a symptomatic LQTS patient. Shown are the longitudinal (left) and circumferential (right)
strain curves from a symptomatic LQTS patient. The anterior basal septal segment from longitudinal strain (left, red curve) shows a
contraction duration of 460 milliseconds. From circumferential strain, the contraction duration from the anterior basal septal segment
(right, yellow curve) is 360 milliseconds. Subendocardial contraction duration (longitudinal strain) therefore is markedly prolonged com-
pared with midmyocardial contraction duration (circumferential strain), indicating transmural mechanical dispersion.
Table 1. Clinical Characteristics and Echocardiographic Findings
in 101 LQTS Mutation Carriers and 35 Healthy Individuals
Healthy
Individuals
(n35)
LQTS
Patients
(n101) P
Age, y 3410 3716 0.32
Heart rate, bpm 6910 6513 0.27
Women, n (%) 20 (57) 71 (70) 0.21
EF, % 645 646 0.83
Global strain, % 22.62.0 21.41.8 0.009
Mean contraction duration,
longitudinal, ms
39040 44545 0.001
Mean contraction duration,
circumferential, ms
38545 43050 0.001
Mechanical dispersion,
longitudinal, ms
207 3615 0.001
Mechanical dispersion,
circumferential, ms
1411 3623 0.001
Delta contraction duration,
longitudinal, ms
5520 11050 0.001
Delta contraction duration,
circumferential, ms
2525 8855 0.001
EF indicates ejection fraction. Values are meanSD when appropriate.
P values are from unpaired t test and Fisher exact test.
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patients and healthy individuals. Ejection fraction was normal
in LQTS subjects regardless of previous arrhythmias. LQTS
patients had longer QTc compared with healthy individuals
(48045 versus 39020 milliseconds; P0.001). Despite
apparently normal systolic LV function, mean contraction
duration was significantly longer in LQTS patients compared
with healthy individuals in longitudinal and circumferential
measurements (both P0.001). The abnormal myocardial
function in LQTS mutation carriers was further confirmed by
a significantly more pronounced mechanical dispersion (het-
erogeneous contraction) compared with healthy individuals
(P0.001). Finally, delta contraction duration, reflecting the
difference between the longest and shortest contraction dura-
tions, was prolonged in LQTS patients (P0.001). Global
strain as a marker of systolic function was within normal
range in LQTS patients but was significantly reduced com-
pared with healthy individuals (P0.009).
Results in Symptomatic Compared With
Asymptomatic LQTS Mutation Carriers and
Arrhythmia Risk Evaluation
Symptomatic LQTS mutation carriers had longer QTc
(P0.001) and pronounced QTc dispersion (P0.04) com-
pared with asymptomatic mutation carriers (Table 2). Mean
contraction duration was longer in symptomatic LQTS mu-
tation carriers compared with asymptomatic carriers in lon-
gitudinal (P0.001) and circumferential (P0.03) measure-
ments. In symptomatic LQTS patients, mean contraction
duration measured by longitudinal strain was significantly
longer compared with circumferential strain (46045 versus
44545 milliseconds; P0.008), reflecting transmural me-
chanical dispersion. Significant differences between suben-
docardial and midmyocardial contraction durations were
present in the following segments in symptomatic LQTS
mutation carriers: posterior septal: 46560 milliseconds for
longitudinal versus 41550 milliseconds for circumferential,
P0.001; anterior septal: 47065 milliseconds for longitu-
dinal versus 44060 milliseconds for circumferential,
P0.04; anterior segment: 48565 milliseconds for longitu-
dinal versus 44565 milliseconds for circumferential,
P0.02; posterolateral segment: 48050 milliseconds for
longitudinal versus 42565 milliseconds for circumferential,
P0.01; and posterior segment: 48065 milliseconds for
longitudinal versus 44065 milliseconds for circumferential,
P0.003. In asymptomatic LQTS mutation carriers and
healthy individuals, there were no significant differences in
mean contraction duration measured by longitudinal com-
pared with circumferential strain (P0.31 and P0.99,
respectively), indicating an absence of transmural mechanical
dispersion.
Mechanical dispersion, assessed as the SD of contraction
duration, was significantly greater in symptomatic LQTS
mutation carriers compared with asymptomatic patients in
both strain directions (P0.001; Table 2 and Figure 3). The
time differences between the longest and the shortest con-
traction durations longitudinally and circumferentially (delta
contraction durations) were significantly longer in symptom-
atic LQTS mutation carriers (P0.001). As determined by
ROC analysis, longitudinal mechanical dispersion could bet-
ter discriminate between LQTS mutation carriers with and
without cardiac events compared with QTc with an AUC of
0.87 (95% confidence interval [CI], 0.79 to 0.94; Figure 4).
The AUC for mechanical dispersion was significantly higher
compared with the AUC for QTc (AUC, 0.71; 95% CI, 0.61
to 0.81; P0.01). QTc 460 milliseconds showed a sensi-
tivity of 42% (95% CI, 29 to 57) and a specificity of 81%
(95% CI, 67 to 91) for identifying mutation carriers with a
history of events. The optimal cutoff value for mechanical
dispersion was 33 milliseconds and identified mutation
carriers with a history of events with a sensitivity of 76%
(95% CI, 61 to 87) and a specificity of 91% (95% CI, 78 to
98). There was a modest but significant correlation between
QTc dispersion by ECG and mechanical dispersion by echo-
cardiography (r0.30, P0.007).
The echocardiographic study was repeated in 10 patients
after a median of 16 months (range, 6 to 38 months). No
changes in medication were initiated in these patients
between the 2 echocardiographic studies. Contraction du-
ration and mechanical dispersion did not change signifi-
cantly over time. Contraction durations at the first and
second echocardiographic studies were 46565 and
43530 milliseconds, respectively (P0.12). Mechanical
Table 2. Clinical Characteristics and Echocardiographic
Findings in 53 Asymptomatic and 48 Symptomatic LQTS
Mutation Carriers
Asymptomatic
LQTS Patients
(n53)
Symptomatic
LQTS Patients
(n48) P
Age, y 4114 3216 0.002
Heart rate, bpm 6713 6413 0.22
Women, n (%) 32 (60) 39 (81) 0.03
EF, % 646 645 0.50
Global strain, % 21.21.6 21.51.9 0.41
QTc, ms 46030 49550 0.001
QTc dispersion, ms 4817 5623 0.04
LQT1, n (%) 40 (75) 24 (50) 0.005
LQT2, n (%) 12 (23) 14 (29) 0.81
LQT3, n (%) 1 (2) 0 (0) 0.99
LQT5, n (%) 0 (0) 1 (2) 0.48
JLNS, n (%) 0 (0) 9 (100) 0.001
Mean contraction duration,
longitudinal, ms
42545 46040 0.001
Mean contraction duration,
circumferential, ms
41555 44045 0.03
Mechanical dispersion,
longitudinal, ms
2712 4513 0.001
Mechanical dispersion,
circumferential, ms
2621 4622 0.001
Delta contraction duration,
longitudinal, ms
8540 13050 0.001
Delta contraction duration,
circumferential, ms
5550 10055 0.001
EF indicates ejection fraction. Values are meanSD when appropriate.
P values are from unpaired t test and Fisher exact test.
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dispersions at the same occasions were 4319 and 3710
milliseconds (P0.17).
All longitudinal time measurements were repeated by
the TDI method because of the higher temporal resolution.
These time measurements showed results similar to those of
speckle tracking (data not presented). The intraclass correla-
tion between contraction duration by TDI and the speckle
tracking technique was 0.84.
-Blocker therapy was more common in symptomatic
LQTS mutation carriers (85%) compared with asymptomatic
carriers (21%; P0.001). However, heart rate at the time of
echocardiographic examination was not significantly differ-
ent in the 2 groups (Table 2).
Genotype Subgroup Analyses
Subgroup analyses of LQT1 (n64) and LQT2 (n26)
single-mutation carriers did not show significant differences
in QTc (47035 versus 47030 milliseconds; P0.85) or
mean contraction duration longitudinally (43545 versus
44550 milliseconds; P0.50) or circumferentially
(43055 versus 42045 milliseconds; P0.40). Longitudi-
nal mechanical dispersion tended to be more pronounced in
LQT2 compared with LQT1 patients (3714 versus 3114
milliseconds; P0.10). In double-mutation carriers (JLNS
patients; n9), QTc was prolonged compared with single-
mutation carriers (56050 versus 47035 milliseconds;
P0.001). Mean longitudinal contraction duration was pro-
longed (47535 versus 44045 milliseconds; P0.02), but
not in the circumferential direction (43045 versus 43050
milliseconds; P0.98), compared with single-mutation carri-
ers. Longitudinal mechanical dispersion was more pro-
nounced in JLNS patients compared with single-mutation
carriers (5413 versus 3414 milliseconds; P0.002).
Figure 5 demonstrates that transmural mechanical disper-
sion was prominent in LQT2 patients in the posterior septal,
anterior septal, and anterior segments. Transmural mechani-
cal dispersion was not present in asymptomatic LQT2 muta-
tion carriers. In JLNS patients, significant transmural me-
chanical dispersion was present in the posterior septal,
anterior septal, anterior, posterolateral, and posterior seg-
ments. In LQT1 single-mutation carriers, transmural mechan-
ical dispersion did not reach significant levels in analysis of
symptomatic LQT1 patients separately.
Discussion
This study confirms that LQTS patients have myocardial
contraction abnormalities. A novel observation in the present
study was that LQTS patients have abnormally prolonged
contraction in the LV long axis, which reflects the function of
myocardial fibers located predominantly in the subendocar-
Figure 3. Myocardial strain curves from the apical long-axis view in a healthy individual (left) and an LQTS patient (right). Contraction
duration is homogeneous in all 6 segments in the healthy individual (370 milliseconds). The LQTS patient shows prolonged contraction
duration (460 milliseconds) in the 3 septal segments (red, dark blue, and pink strain curves), indicating dispersed myocardial contrac-
tion. AVC indicates aortic valve closure.
Figure 4. ROC curves of cardiac events in 101 LQTS mutation
carriers. Mechanical dispersion demonstrates better discrimina-
tion of patients who experience cardiac events compared with
QTc. AUC for mechanical dispersion is 0.87 (95% CI, 0.79 to
0.94) versus 0.71 for QTc (95% CI, 0.61 to 0.81; P0.01).
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dium. The symptomatic LQTS patients in our study had
longer contraction duration in the subendocardial layer com-
pared with the mid layer of the ventricular wall, indicating
transmural mechanical dispersion. Transmural differences in
contraction durations were present in most LV segments,
were related to risk for cardiac arrhythmias, and were most
evident in LQT2 and JLNS patients. This study indicates that
regional myocardial dysfunction may reflect electric distur-
bances and may be helpful in exploring arrhythmogenesis in
these patients.
Electric Dysfunction and Mechanical
Consequences in LQTS
Ion channel defects in LQTS lead to prolonged APD. Ion
channels are not homogeneously distributed throughout the
myocardium. Defective ion channels will therefore lead to an
inhomogeneous prolongation of APD and will ultimately
result in dispersion of electric repolarization.2 Findings from
LQTS patients have implicated a specific role for early
afterdepolarizations and dispersion of electric repolarization
in ventricular arrhythmogenesis.20,21 Furthermore, there is
strong evidence that early afterdepolarizations lead to pro-
longed repolarization, which has been linked to myocardial
contraction abnormalities.8,9The findings in our study support
that prolonged APD results in prolonged regional ventricular
contraction and are in accordance with previous studies.8–10
The pronounced mechanical dispersion found in our LQTS
patients was related to ventricular arrhythmias and is likely to
reflect electric dispersion. Heterogeneous ventricular contrac-
tion can also be caused by fibrosis in myocardial tissue and
has been related to ventricular arrhythmias22 and death23 in
patients after myocardial infarction.
Dispersion of repolarization can occur between the apex
and base, ie, longitudinally and transmurally, and can facili-
tate the generation of torsade de pointes arrhythmia.21 The
measurement of QT dispersion on ECG as an indicator of
dispersion of ventricular repolarization was presented as a
promising tool in risk stratification of arrhythmias 2 decades
ago.15,16 However, the method has not achieved the clinical
value initially expected because of challenges in T-wave
definition and relatively low reproducibility.7 Our study
showed pronounced QTc dispersion in LQTS mutation car-
riers with arrhythmic events compared with those without
arrhythmic events (Table 2). This is in accordance with
previous studies showing pronounced QT dispersion in LQTS
patients with recurrent arrhythmic events.16 The significant
correlation to mechanical dispersion in our study supports the
assumption that our echocardiographic findings may reflect
electric dispersion of repolarization.
With the method presented in this study, we were able to
quantify longitudinal (between the apex and base) and inter-
regional (between the interventricular septum, lateral wall,
anterior wall, and posterior wall) mechanical dispersion. In
addition, we were able to provide a measure of mechanical
transmural dispersion in comparisons of the duration of
longitudinal strain with circumferential strain. The fiber
orientation in LV is complex. In the subendocardium, the
fibers have a predominantly longitudinal direction with an
angle of 80° with respect to the circumferential direction.24,25
A recent experimental study demonstrated that differences in
the timing of contraction between circumferential and longi-
tudinal shortening in 1 LV segment were attributed to the
electric sequence.25 The subendocardial fibers contribute
mainly to longitudinal contraction, whereas the midmyocar-
dium fibers contribute mainly to circumferential contrac-
tion.13 Therefore, differences in the timing of contraction in
these directions reflect the transmural mechanical heteroge-
neity caused by electric dysfunction.
Mechanical Abnormalities in LQTS Patients
Mean contraction duration was prolonged in LQTS mutation
carriers compared with healthy individuals and in symptom-
atic LQTS mutation carriers compared with asymptomatic
carriers. Contraction duration by longitudinal strain (suben-
Figure 5. Contraction duration by cir-
cumferential and longitudinal strain in 64
LQT1 and 26 LQT2 mutation carriers
and in 9 JLNS patients. In LQT2 muta-
tion carriers (top), longitudinal contrac-
tion durations (bottom values, italics) in
the septal and anterior segments were
longer compared with circumferential
contraction durations (top values) in the
same segments. In JLNS patients (right),
longitudinal contraction duration was
longer compared with circumferential in
all segments except the anterolateral
segment. P values were obtained by
paired t test; signiﬁcant P values are
presented. Longitudinal contraction
durations were signiﬁcantly longer in
JLNS patients compared with LQT1 and
LQT2 single-mutation carriers.
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docardial layers) was significantly longer than by circumfer-
ential strain (midmyocardial layers) in symptomatic LQTS
patients. These findings indicate a transmural mechanical
dispersion in symptomatic LQTS patients that was not pres-
ent in asymptomatic and healthy individuals. These mechan-
ical findings are in accordance with previous electric LQTS
models reporting the longest APD in Purkinje cells and M
cells located in the subendocardium and midmyocardi-
um.4,5,26 The APD of subendocardial Purkinje fibers in vitro
has been reported to be even longer than in the M cells, but
the delayed repolarization of the Purkinje system has failed to
register on the ECG.5 Purkinje cells are found in the His
bundle and bundle branches and cover much of the endocar-
dium.26 The transmural mechanical dispersion in this study
may represent the transmural electric dispersion of repolar-
ization that is shown to be present in LQTS models and is
suggested to be a strong arrhythmogenic factor.21 In symp-
tomatic LQT2 patients, the transmural dispersion was present
in the interventricular septum and anterior LV wall. Septal
cells may play a specific role in arrhythmogenesis in LQTS.27
It has been indicated that M cells in the interventricular
septum are located in the deep subendocardium and exert a
strong electrotonic influence to prolong APD in neighboring
endocardial cells.5 Despite the limited number of genotype
subgroup participants, transmural mechanical dispersion was
pronounced in LQT2 patients and patients with JLNS. This
finding may indicate genotype-specific differences in electric
dispersion and are in accordance with the higher arrhythmic
risk in patients with these genotypes.28,29
Interestingly, our study indicates that novel echocardio-
graphic methods can detect prolonged contraction in the
subendocardial layers and support experimental electrophys-
iological reports. Our findings support the idea of LQTS as a
regional disease, with the most prolonged contraction duration in
the subendocardium in mutation carriers with arrhythmias.
Future studies are needed to explore whether contraction abnor-
malities can add information about arrhythmogenicity in other
channelopathies.
Global strain has been reported as a sensitive marker of
systolic function.17 Global strain was within the normal range
in LQTS patients but was reduced compared with healthy
individuals. This finding may indicate that the contraction
abnormalities in these patients may lead to subclinical im-
pairment of myocardial function.
Electromechanical Interactions in LQTS
Sporadic but consistent awareness that electric alterations in
LQTS patients have mechanical consequences has arisen
during the past 20 years.8,9,30,31 We recently reported pro-
longed myocardial contraction duration and mechanical dis-
persion by myocardial velocities in LQTS patients that were
associated with increased risk for ventricular arrhythmias.10
However, our recent report and earlier studies were not
designed to distinctly quantify separate regions of the myo-
cardium for comparison. In this study, we have used myo-
cardial strain measurements instead of velocity measure-
ments. Myocardial velocities have limited ability to reflect
regional myocardial function.12 In contrast, myocardial strain
measurements can identify myocardial dysfunction of a more
regional character and can accurately assess myocardial
shortening in a distinct part of the ventricle. With this
method, we were able to investigate the regional nature of
contraction prolongation in LQTS patients.
Time measurements can be performed by speckle tracking
and TDI techniques. In our study, contraction duration
measured by both techniques showed similar results. The
speckle tracking technique has lower temporal resolution than
TDI, but it is less ultra-beam-angle dependent and more
attractive to use. The preferred technique depends on the
investigator’s experience.
The specific patterns of myocardial contraction abnormal-
ities described in our study may depend on the concomitant
electric disorder in these patients. It is well established that
electric alterations are a prerequisite to arrhythmogenic ac-
tivity. A careful tracing of myocardial strain will thus
increase our knowledge of the pathophysiology in LQTS
patients and may contribute to risk stratification in clinical
routine.
Clinical Implications
Genetic testing for LQTS has become more available; con-
sequently, family screening has led to asymptomatic family
mutation carriers making up a great number of consultations
at the outpatient clinic. The overall risk that asymptomatic
adult mutation-positive family members will experience
spontaneous arrhythmias during their lifetime is low, and in
these individuals, QTc has failed to be a significant predictor
of outcome.32 Prophylactic treatment involves lifelong
-blocker therapy.33 Determining whether these family mem-
bers are true silent mutation carriers and do not need
prophylactic medication is often difficult.
By ROC analysis, the best parameter for arrhythmia risk
assessment in this study was longitudinal mechanical disper-
sion. This parameter reflects heterogeneity in regional con-
traction duration and was superior to QTc in discriminating
between LQTS patients with and without arrhythmic events.
Our findings suggest that echocardiography might be a
complementary tool to QTc in risk stratification of LQTS
mutation carriers and may provide added value in risk
stratification of asymptomatic adult mutation carriers.
Limitations
The relationship between mechanical dispersion and electric
dispersion should be studied in invasive electrophysiological
studies. It may be speculated that -blocker medication might
influence contraction duration and our data. However, heart
rate was not significantly different in asymptomatic and
symptomatic patients, and all time measurements were cor-
rected for heart rate by the Bazett formula. In addition, our
recent study comparing healthy individuals on -blocker
medication with LQTS patients could not attribute prolonged
contraction duration to the use of -blocker medication.10
Our study did not provide data that demonstrated that
LQTS patients with pronounced mechanical dispersion had a
higher risk of future arrhythmic events. This requires a
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prospective study in which so far asymptomatic and untreated
patients are followed up for an adequate period of time. This
study design is difficult for ethical reasons.
Conclusions
LQTS patients have regional myocardial dysfunction that can
be assessed by myocardial strain. Myocardial contraction
duration is prolonged in LQTS mutation carriers and most
prolonged in those with arrhythmic events. LQTS mutation
carriers with arrhythmic events have longer contraction du-
ration in the subendocardial layer compared with the mid
layer of the ventricular wall, indicating transmural mechani-
cal dispersion that is not present in asymptomatic LQTS
mutation carriers and healthy individuals. Transmural disper-
sion is located predominantly in the interventricular septum
and anterior LV wall in LQT2 patients and patients with
JLNS.
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CLINICAL PERSPECTIVE
The long-QT syndrome (LQTS) is due to inherited cardiac ion channel defects and predisposes to life-threatening
ventricular arrhythmias and sudden cardiac death. Current risk stratification of ventricular arrhythmias is based on a history
of syncope or documented arrhythmia, heart rate–corrected QT interval on the ECG (QTc), gender, and genotype.
However, QTc is insufficient as a significant predictor of arrhythmic outcome. LQTS has traditionally been regarded as
a purely electric disease. Strain by echocardiography can accurately quantify regional myocardial timing and function.
Echocardiography was performed in 101 genotyped LQTS patients (53 asymptomatic and 48 with a history of cardiac
arrhythmias) and 35 healthy control subjects. Left ventricular contraction pattern by strain was assessed as time from the
ECG Q wave to maximum myocardial shortening in 16 LV segments. Strain was assessed along the longitudinal axis,
predominantly representing subendocardial fibers, and along the circumferential axis, representing midmyocardial fibers.
This study shows that LQTS patients have abnormal LV contraction patterns. Contraction duration was longer and more
heterogeneous in symptomatic LQTS mutation carriers compared with asymptomatic patients. In addition, contraction
duration was longer in the subendocardium than in the midmyocardium, indicating a pronounced transmural mechanical
dispersion that was not present in asymptomatic and healthy individuals. Our findings suggest that echocardiography might
be a complementary tool to QTc and may provide added value in risk stratification of LQTS mutation carriers.
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Introduction 
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a chronic, progressive, 
heritable cardiomyopathy and is one of the leading causes of sudden unexpected cardiac death in 
previously healthy young individuals 1, 2. The first clinical symptom may present as life-
threatening arrhythmias  
ARVC was initially recognized as a disease of the right ventricular (RV) myocardium, but 
involvement of the left ventricular (LV) myocardium is now commonly recognized 3-6. Four 
clinical stages have been documented: An early concealed phase, overt electrical disorder, 
isolated right heart failure, and biventricular pump failure 2, 4.  
Recent molecular genetic reports have revealed ARVC as mainly an autosomal dominant 
inherited desmosomal disease 7, leading to progressive loss of cardiac myocytes, followed by 
fibro-fatty replacement. Penetrance is age and gender dependent and the progressive clinical 
picture is highly variable 8. Importantly, life-threatening arrhythmias can occur with only discrete 
or even absent myocardial structural changes 9, 10. Risk stratification of malignant arrhythmias in 
so far asymptomatic mutation carriers is therefore challenging.  
Echocardiographic studies of the RV in ARVC patients have shown that RV dilatation 
and reduced regional or global RV function are traits of the disease. Quantitative assessment of 
RV function is difficult due to complicated anatomy and load dependency. Reviewed guidelines 
for diagnosing ARVC from 2010 have improved quantitative assessment of RV dysfunction, 
including measures of RVOT and RV area 11.  
Strain by echocardiography has been introduced as an accurate tool for assessment of 
regional12  and global myocardial function13  and recent reports have shown that RV function can 
be accurately assessed by this method 14. 
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Electrical conduction delay with consequent electrical dispersion has been suggested as a 
mechanism of ventricular arrhythmias in ARVC patients 15, 16. Mechanical dispersion 
(heterogeneous contraction) assessed by myocardial strain may reflect electrical dispersion and 
has recently been demonstrated to relate to malignant ventricular arrhythmias in patients with 
long QT syndrome 17 and in patients after myocardial infarction 18.  
We hypothesized that pronounced mechanical dispersion by myocardial strain is associated with 
susceptibility to ventricular arrhythmia in patients with ARVC and therefore may be an additional 
tool for arrhythmia risk stratification. Furthermore, we aimed to investigate to what extent LV 
function assessed by strain echocardiography was reduced along with RV function in patients 
with ARVC diagnosis and in asymptomatic mutation carriers. 
Methods
In total, 59 patients (Table 1) were included. Of these, 36 were diagnosed with ARVC 
based on the modified International Task Force criteria from 2010 11, 23 patients were 
asymptomatic mutation carriers included by family cascade genetic screening (Table 2).  
The medication received at the time of the echocardiographic study and the presence of an 
implanted cardioverter defibrillator (ICD) was recorded.  
Healthy control subjects were recruited from the hospital staff. They had normal 
electrocardiogram (ECG), physical examination, echocardiographic study and were free from 
disease with potential impact on the cardiovascular system.  
Written informed consent was given by all study participants. The study complies with the 
Declaration of Helsinki and is approved by the Regional Committee for Medical Research Ethics 
(NEM South). 
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Genetic analyses  
Genomic DNA was isolated from peripheral blood in patients with ARVC phenotype. The 
individual exons with flanking intron sequences of the genes plakophilin-2 (PKP2), desmoglein-2
(DSG-2) and desmoplakin (DSP) and 29 of the 105 exons of the ryanodine receptor-2 (RYR2) 
gene were sequenced by polymerase chain reaction amplification in combination with direct 
sequencing. Cascade genetic screening was performed in family members of mutation positive 
ARVC patients.  
Two-dimensional (2D) Echocardiography  
Patients and control subjects underwent an echocardiographic study (Vivid 7, General 
Electric, Vingmed, Horten, Norway). Cineloops from 3 standard apical views (4-chamber, 2-
chamber and apical long-axis) were recorded using grey-scale harmonic imaging. Data were 
digitally stored for off-line analysis using software (EchoPac, General Electric, Vingmed, Horten, 
Norway). The echocardiographic data were analyzed blinded to all clinical information including 
presence of arrhythmia in ARVC patients.  
From 2D echocardiography the following parameters were assessed: Right ventricular 
outflow tract (RVOT) diameter in the parasternal short axis view, right ventricular end-diastolic 
(RVED) area, right ventricular end-systolic (RVES) area and right ventricular area fraction 
(RVAF) from apical 4 chamber view11. 
2D Strain and Dispersion  
The endocardial borders were traced in the end-systolic frame of the 2D images from the 
3 apical views for LV strain and from the 4-chamber view for RV strain. Speckles were tracked 
frame-by-frame throughout the LV and RV wall during the cardiac cycle. Segments that failed to 
track, were manually adjusted by the operator. Any segments that subsequently failed to track, 
were excluded. Peak systolic myocardial strain by 2D speckle tracking echocardiography was 
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assessed in 16 LV segments and averaged to LV global longitudinal strain. Peak systolic strain 
from 3 RV free wall segments was averaged as a measure of RV function (RV strain). 
Contraction duration (CD) (Figure 1) was measured as time from onset R on ECG to maximum 
LV and RV shortening by strain. Standard deviation (SD) of CD was calculated as a parameter of 
mechanical dispersion, in a 16 LV segment and a 6 RV segment model.  
We used a 6 RV segment model (3 RV free wall segments plus 3 septal segments) when 
assessing mechanical dispersion which includes the usually less affected interventricular 
septum11 to elucidate dispersion of contraction between affected and non-affected segments. 
Magnetic Resonance Imaging (MRI) 
MRI was performed using 1.5 Tesla units (Magnetom Vision Plus or Magnetom Sonata, 
Siemens, Erlangen, Germany) and a phased array body coil. Axial and sagital T1 TSE images, 
multiple axial and one sagital cineloop covering the RV and LV were recorded. RV and LV 
chamber dimensions, wall thickness, fatty infiltration and myocardial function were assessed. 
Signal-Averaged ECG (SAECG) 
SAECG was performed using a MAC® 5000-analysing system (GE Medical Systems, 
Milwaukee, Wisconsin, USA). Time domain analysis was obtained in the bandpass filter 40 to 
250 Hz. The SAECG was considered positive for late potentials when at least two of the 
following parameters were abnormal: total filtered QRS duration (fQRSd) >114 ms, the terminal 
(last 40ms) QRS root mean square voltage (RMS) <20V and the low amplitude (<40V) late 
potential duration (HFLA) >38 ms.  
Statistical analyses 
Analyses were carried out using a standard statistical software program (SPSS version 16, 
SPSS Inc, Chicago, Ill). Data were presented as mean ± SD and numbers and percentages, 
respectively. The chi-square test was used to determine differences between 2 groups of 
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categorical variables. Student-t test was used to compare differences between 2 groups for 
continuous variables. Comparisons of means were performed by analysis of variance (ANOVA) 
with the Bonferroni post hoc correction for multiple comparisons. Correlation between RV and 
LV strain was assessed by linear regression analysis. The value closest to the upper left corner of 
the receiver-operator characteristic curve determined optimal sensitivity and specificity for the 
ability of RV mechanical dispersion to identify arrhythmic events. P-values were two-tailed, 
values below 0.05 were considered significant. 
Results 
Among 59 patients in this study, 36 (61%) had symptomatic ARVC, while 23 (39%) were 
asymptomatic mutation carriers, diagnosed by cascade genetic screening. ARVC related 
mutations were confirmed in 43 (73%) of all patients, [37 (86%) PKP2, 5 (12%) DSP and 1 (2%) 
RYR2]. No mutations were found in 16 (44%) ARVC patients.   
Ventricular arrhythmias (Ventricular Tachycardia (VT) or Ventricular Fibrillation (VF)) 
were documented in all 36 ARVC patients and 78% of the ARVC patients received anti 
arrhythmic medical therapy at the time of the echocardiographic study. An ICD was implanted in 
33 (92%) of the ARVC patients.  
Complete right bundle branch block (RBBB) was present in 3 (9%) and incomplete right 
bundle branch block in 4 (12%) ARVC patients. 
MRI studies were completed in 16 (70%) asymptomatic mutation carriers and in 25 (70%) 
ARVC patients. Negative MRI study regarding ARVC phenotype was found in 8 (50%) 
asymptomatic mutation carriers and in 4 (16%) ARVC patients.   
Pathological SAECG was significantly more frequent in ARVC patients compared to 
asymptomatic mutation carriers (p=0.03) (Table 3). QRS duration assessed by ECG and total 
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filtered QRS duration (fQRSd) assessed by SAECG were prolonged in ARVC patients compared 
to asymptomatic mutation carriers (0.03 and 0.05, respectively) (Table 3).  
Mechanical dispersion in ARVC patients
ARVC patients with arrhythmias showed a marked increase in RV and LV mechanical 
dispersion compared to asymptomatic mutation carriers (p<0.01 and p<0.001) and healthy 
controls (both p<0.001) (Table 4). Importantly, asymptomatic mutation carriers showed 
significantly increased RV and LV mechanical dispersion compared to healthy controls (p<0.01 
and p<0.001), indicating subclinical myocardial alterations. A receiver operator characteristic 
(ROC) analysis demonstrated that RV mechanical dispersion greater than 42 ms identified 
arrhythmic events in ARVC patients with a sensitivity of 81% and a specificity of 65% (Figure 
2).
Table 5 shows 4 patients (2 presented with VF and 2 with VT) with normal conventional 
echocardiographic and MRI findings. Despite normal conventional imaging, all 4 had significant 
increase in mechanical dispersion in RV (48±11ms) and LV (52±11ms) compared to healthy 
individuals (both p<0.001). Three of them had an ARVC related mutation and 1 patient 
progressed subsequently to typical ARVC phenotype. 
RV and LV function 
ARVC patients with arrhythmias showed significantly reduced RV and LV function 
assessed by myocardial strain compared to asymptomatic mutation carriers (p<0.01 and p<0.001) 
and healthy controls (both p<0.001). LV ejection fraction (EF) was within normal range in 
ARVC patients with arrhythmias, but was significantly reduced compared to healthy individuals 
(p<0.01) (Table 4). 
LV and RV functions by strain were significantly correlated in symptomatic ARVC 
patients (R=0.84, p<0.001) (Figure 1). Importantly, this relationship was present in symptomatic 
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ARVC patients with reduced RV function by visual assessment, indicating biventricular disease 
in patients with “classic” right ventricular involvement. Reduced LV strain (> -20%) was found 
in 27 of 36 (75%) patients and 27 (75%) patients had reduced RV strain (> -25%). Reduced 
myocardial function in both ventricles was present in 23 (64%) patients. Four (11%) patients had 
reduced LV strain along with normal RV strain and 4 (11%) patients had reduced RV strain with 
normal LV strain. Normal myocardial function in both ventricles was only present in 3 patients 
(8%).   
Asymptomatic mutation carriers had LV strain within normal range (-20 ± 2 %), but 
importantly, RV and LV function assessed by strain were significantly reduced compared to 
healthy individuals (p<0.05), indicating subclinical myocardial impairment (Table 4). 
ARVC patients with arrhythmias had significantly increased RVOT diameter, RVED area 
and RVES area (p<0.001, p=0.01 and p=0.003) and significantly reduced RVAF (p=0.001) 
compared to asymptomatic mutation carriers (Table 4). 
Discussion
This study demonstrates that mechanical dispersion assessed by speckle tracking 
echocardiography is closely related to ventricular arrhythmias in patients with ARVC.  Increased 
mechanical dispersion and reduced myocardial strain in both ventricles were present in 
asymptomatic mutation carriers, indicating subclinical myocardial alterations. Importantly, 
pronounced mechanical dispersion was also present in individuals who had experienced 
arrhythmias in the early stages of ARVC when structural alterations assessed by conventional 
echocardiography and MRI were absent. These findings indicate that mechanical dispersion may 
be evaluated as a marker of arrhythmias in so far asymptomatic mutation carriers and may be 
helpful in risk stratification.  
9
  
The relationship between mechanical dispersion and arrhythmias
The diagnosis of ARVC is challenging and the prediction of which patients will develop 
arrhythmias is even more so. No single test is sufficient to diagnose or exclude ARVC and to 
predict arrhythmias. The Task Force criteria from 1994 19 are highly specific but lack sensitivity 
for early stages and familial forms of ARVC. Overall sensitivity have been enhanced by the 2010 
revision 11. However, risk assessment of malignant arrhythmias in the early stages remains a 
challenge. 
The occurrence of malignant arrhythmias in the early stages can precede structural 
myocardial changes shown by traditional imaging techniques. An accurate assessment of 
myocardial function is therefore particularly important in early ARVC, e.g. in so far 
asymptomatic mutation carriers. Myocardial strain by echocardiography has demonstrated to be a 
sensitive tool for assessing ventricular function and timing 20.   
In our study, we demonstrate that evaluation of regional timing in terms of mechanical 
dispersion may add important diagnostic and prognostic information in ARVC, particularly in the 
early stages of the disease.  We demonstrate a significant increase in mechanical dispersion in 
both ventricles in asymptomatic mutation carriers who apparently have structurally and 
functionally normal LV and RV by traditional echocardiography and MRI. More importantly, 
these findings may be used for risk prediction of life-threatening arrhythmias in asymptomatic 
mutation carriers. 
 Interestingly, reduced myocardial strain and increased mechanical dispersion in both 
ventricles showed significant differences between healthy controls and asymptomatic mutation 
carriers. These findings suggest biventricular involvement also in the concealed phase of the 
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disease when structural and functional changes are not apparent if assessed by traditional 
echocardiography or MRI.   
 We have recently demonstrated mechanical dispersion to be related to ventricular 
arrhythmias in patients with long QT syndrome 17. Furthermore, we have introduced mechanical 
dispersion as a predictor of ventricular arrhythmias in patients after myocardial infarction 18. The 
present study shows that mechanical dispersion is present in ARVC patients, and may help to risk 
stratify arrhythmic events. The mechanisms of arrhythmogenesis in infracted tissue and in ARVC 
have similarities in terms of fibrosis and delayed electrical conduction. Altered electrical 
conduction is present in ARVC in the phase of overt electrical disorder, while fibrosis may 
develop later 9, 10. Dispersion of ventricular depolarization-repolarization has been regarded as a 
strong arrhythmogenic factor, although non-invasive assessment of these electrical abnormalities 
have been challenging 16. Electrical abnormalities in diseased myocardium may be translated into 
mechanical alterations. Mechanical dispersion by strain echocardiography appears to be a 
sensitive tool for assessing subtle changes in timing of myocardial contraction.  
Ventricular arrhythmias in ARVC are believed to origin from different mechanisms at 
different stages of the disease. In the concealed phase, inflammatory processes due to apoptosis, 
derangements in cell-to-cell adhesion and altered nuclear signaling are reported to be 
arrhythmogenic 9, 10. A study using immunohistochemistry has shown reduced levels of gap 
junction protein Connexin 43, important for myocardial electrical propagation, in a patient 
homozygous for ARVC mutations, but without visible structural alterations 10. Our study may 
support these findings, indicating subtle contraction heterogeneity in asymptomatic mutation 
carriers. In later stages of the disease, islands of surviving myocytes surrounded by fibro-fatty 
tissue provide a substrate for re-entry ventricular arrhythmias 2, 16. The novelty of the present 
study is the identification of myocardial abnormalities in the early stages, and the potential for 
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prediction of arrhythmias. However, these findings have to be confirmed in a prospective and 
longitudinal study.   
RV and LV dysfunction or biventricular disease  
Initially, ARVC was believed to be a pure RV disease. New subtypes of arrhythmogenic 
cardiomyopathy with LV or biventricular predilection have been recognized 4. Importantly, 
progression from left-dominant to biventricular involvement has also been documented 21.  
LV involvement was first suggested in 1983 3 and has been confirmed in several studies 6,
21, 22. A recent study using echocardiographic tissue Doppler imaging (TDI) showed signs of LV 
involvement in patients with only mildly decreased RV function23,. Our study showed similar 
results. Decreased myocardial strain and increased mechanical dispersion in both ventricles in 
asymptomatic mutation carriers and in symptomatic ARVC patients diagnosed by current 
guidelines 11, suggest early involvement of the LV. Furthermore, LV and RV strain were 
significantly correlated in our ARVC patients. Biventricular impairment is probably a result of 
biventricular ARVC affection, but mutual dependency of RV and LV hemodynamics may be 
considered.  
Current diagnostic tools  
The diagnosis of ARVC is based on the criteria outlined by the International Task Force 19 
in 1994, and revised in 2010 11. Criteria for structural abnormalities are based on 2D 
echocardiographic and MRI findings. Since the establishment of these criteria, several studies 
have confirmed the ability of MRI to detect structural abnormalities and myocardial fatty 
replacement in patients with ARVC 24, 25. Despite, the excellent abilities of MRI to diagnose 
ARVC, our study demonstrates that novel echocardiographic methods were able to detect 
ventricular abnormalities in patients with normal MRI findings. Novel echocardiographic 
methods such as TDI and strain echocardiography are at present not widely used in the diagnostic 
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and prognostic work-up of patients with ARVC. However, since echocardiography is easily 
available, it might be a promising tool for detecting RV and LV abnormalities in patients with 
ARVC.  
 The most significant development of ARVC research the latest years is the identification 
of mutations in genes encoding desmosomal and extradesmosomal proteins 2. Pathogenic 
mutations in the gene encoding the desmosomal protein PKP2 are particularly prevalent and have 
been identified in up to 43% of cases 4, 26, 27. Since the disease is inherited in up to 50% of cases, 
the screening of relatives is important. 
Clinical implications  
Recognizing ARVC as a familial disease has resulted in screening of family members. In 
mutation positive ARVC patients, cascade genetic screening helps focusing resources on affected 
family members. Still, risk stratification in these asymptomatic mutation positive family members 
is challenging and emphasized by the fact that the first manifestation of the disease in 20-50% of 
cases may be cardiac arrest 28. Guidelines for treatment of asymptomatic mutation carriers are 
sparse 27. The novel methods presented in this study demonstrated subclinical myocardial 
impairments which were associated with risk of ventricular arrhythmias. These methods may 
therefore be of help in risk stratification of so far asymptomatic mutation carriers.  
Study limitations 
The echocardiographic data were analyzed blinded to all clinical information. However, 
ICD leads are visible on echocardiography, thus demasking the disease status of the patients. 
We assessed global longitudinal strain but not radial or circumferential strain. This 
measure was chosen because longitudinal strain has been best validated. Measurements are 
reproducible and are easily obtained with only a minor increase of procedure duration. Radial and 
circumferential strains from the RV are more difficult to obtain due to the complicated anatomy.  
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Conclusions
This study demonstrates that mechanical dispersion assessed by speckle tracking 
echocardiography is closely related to ventricular arrhythmias in patients with ARVC. 
Mechanical dispersion was present in asymptomatic mutation carriers, indicating subclinical 
myocardial involvement. Likewise, pronounced mechanical dispersion was present in ARVC 
patients who had experienced ventricular arrhythmias in the early stages of the disease. These 
findings indicate that mechanical dispersion may serve as a risk stratification tool in 
asymptomatic mutation carriers, and be helpful in decisions regarding prophylactic treatment. 
RV and LV function correlated in ARVC patients and asymptomatic mutation carriers, 
which implies that ARVC is a biventricular disease. LV involvement was present at the early 
stages of the disease, and echocardiographic evaluation by strain measurements appears to be a 
sensitive marker of subclinical LV involvement.   
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 Figure Legends 
 
Figure 1. Mechanical dispersion in an asymptomatic mutation carrier (left panel) and an ARVC 
patient with recurrent arrhythmias (right panel). 
Horizontal white arrow indicates contraction duration defined as the time from onset R to 
maximum myocardial shortening. Vertical arrows indicate the timing of maximum myocardial 
shortening in each segment. Right panel shows more pronounced mechanical dispersion. 
 
Figure 2. RV versus LV strain in 36 ARVC patients with arrhythmias. The correlation between 
RV and LV function was R = 0.84, p<0.001. 
 
Figure 3.  Receiver-operator characteristic curve for RV mechanical dispersion. RV mechanical 
dispersion more than 42 ms could identify cardiac arrhythmic events with a sensitivity of 81% 
and a specificity of 65%. Area under curve 0.76 (95% CI 0.75-0.92). 
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Table 1 Clinical characteristics  
 Healthy 
individuals 
(n=30) 
Asymptomatic 
mutation carriers 
(n=23) 
ARVC patients 
with arrhythmia 
(n=36) 
p-value 
 
Age (years) 41.0±15.6 38.3±19.7 44.2±15.5 0.40 
Male n(%) 16(53%) 13(57%) 21(58%) 0.98 
Heart rate (bpm) 66±11 66±13 60±14 0.13 
Mean±SD, Numbers (percentages). Right column shows P-values for ANOVA and chi-square 
tests.  
ANOVA, analysis of variance 
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Table 2. Findings according to current International Task Force criteria (2010) 
  Asymptomatic 
mutation carriers 
(n=23) 
ARVC patients 
with arrhythmia 
(n=36) 
p-value 
 
Major 21(91%) 22(61%) 0.01 Positive family 
history n(%) Minor 20(87%) 11(31%) <0.001 
Major 0 8(23%) 0.01 ECG depolarization/ 
conduction abnormalities n(%)  Minor 5(25%) 15(56%) 0.04 
Repolarization 
Abnormalities n(%) 
Minor 3(13%) 20(57%) 0.001 
Tissue characterization  
of walls n(%) 
Major N/A N/A N/A 
Major 2(9%) 18(50%) 0.001 Global and/or regional 
dysfunction and structural  
alterations by 
echocardiography/MRI n(%) 
Minor 6(27%) 13(36%) 0.49 
Arrhythmias n(%) Minor 0 36(100%) <0.001 
Mean±SD, Numbers (percentages). Right column shows P-values for ANOVA and chi-square 
tests.  
ANOVA, analysis of variance; N/A=Not Applicable 
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 Table 3. ECG and SAECG findings  
 Asymptomatic 
mutation carriers 
(n=23) 
ARVC patients 
with arrhythmia 
(n=36) 
p-value 
 
QRS(ms) 93±12 104±23 0.03 
QTc(ms) 424±26 440±37 0.07 
SAECG fQRSd(ms) 109±28 126±27 0.05 
SAECG HFLA(ms) 38±14 47±29 0.20 
SAECG RMS(V) 33±19 26±22 0.25 
SAECG positive(n) 5(25%) 16(57%) 0.03 
 
Mean±SD, Numbers (percentages). Right column shows P-values for ANOVA and chi-square 
tests.  
ANOVA, analysis of variance; fQRSd, filtered QRS duration; HFLA,Low amplitude (<40V) 
late potential duration; QTc, QT interval corrected for heart rate; RMS, terminal (last 40ms) QRS 
root mean square voltage 
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Table 4. Echocardiographic results  
 Healthy 
individuals 
(n=30) 
Asymptomatic 
mutation carriers 
(n=23) 
ARVC patients 
with arrhythmia 
(n=36) 
p-value 
 
EF(%) 64±5 63±4 57±14* <0.01 
LV GLS(%) -23±2 -20±2* -16±5*·** <0.001 
RV strain(%) -28±5 -24±5* -19±7*·** <0.001 
LV Dispersion(ms) 22±8 42±13* 64±25*·** <0.001 
RV Dispersion(ms) 15±8 33±20* 53±25*·** <0.001 
PSAX RVOT(mm)  28±3 33±4 <0.001 
RVED area(cm²)  25±6 30±7 0.01 
RVES area(cm²)  15±5 20±7 0.003 
RVAF(%)  44±7 35±10 0.001 
Mean±SD. Right column shows P-values for ANOVA test. Flags for significance are obtained 
from the post hoc pair-wise comparison using the Bonferroni correction. 
*p<0.05 compared with healthy individuals.  
**p<0.01 compared with asymptomatic mutation carriers.  
ANOVA, analysis of variance; EF, ejection fraction; GLS, global longitudinal strain; PLAX, 
parasternal short axis; RVAF, right ventricular area fraction; RVED, right ventricular end-
diastolic; RVES, right ventricular end-systolic; RVOT, right ventricular outflow tract 
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Table 5. Patients with normal echocardiographic and MRI studies at the time of presentation with 
life threatening arrhythmia  
 32 year old female 34 year old male 58 year old male 38 year old male 
LVEF(%) 60 64 75 57 
LVGLS(%) -19 -16 -21 -18 
RVstrain(%) -21 -20 -19 -27 
LV Dispersion(ms) 41 45 57 65 
RV Dispersion(ms) 52 33 58 52 
SAECG neg pos pos pos 
Mutation pos pos neg pos 
Arrhythmia VF VT VT VF 
EF, ejection fraction; GLS, global longitudinal strain; LV, left ventricle; RV, right ventricle; 
SAECG, signal-averaged ECG; VF, ventricular fibrillation; VT, ventricular tachycardia 
 
 
 
 
 
 
 
 
25
 Figure 1. Mechanical dispersion in an asymptomatic mutation carrier (left panel) and an ARVC 
patient with recurrent arrhythmias (right panel). 
Horizontal white arrow indicates contraction duration defined as the time from onset R to 
maximum myocardial shortening. Vertical arrows indicate the timing of maximum myocardial 
shortening in each segment. Right panel shows more pronounced mechanical dispersion. 
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 Figure 2. RV versus LV strain in 36 ARVC patients with arrhythmias. The correlation between 
RV and LV function was R = 0.84, p<0.001. 
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 Figure 3.  Receiver-operator characteristic curve for RV mechanical dispersion. RV mechanical 
dispersion more than 42 ms could identify cardiac arrhythmic events with a sensitivity of 81% 
and a specificity of 65%. Area under curve 0.76 (95% CI 0.75-0.92). 
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